PIPERAZINE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF

Abstract: The present invention relates to a novel compound of general formula (I) and its pharmaceutically acceptable acid addition salt, and process for the preparation thereof, which have strong antitumor activities and very low toxicity, wherein R1 and R2 are independently hydrogen, C1-C4 alkyl, C1-C4 alkylcarboxyl, C1-C4 alkylcarbonyl, C1-C4 alkoxy, C1-C4 hydroxyalkyl, C1-C4 aminoalkyl or C1-C4 hydroxyiminoalkyl, or R1 and R2 are fused to form C3-C4 unsaturated ring; R3, R4, R5, R6 and R7 are independently hydrogen, halogen, hydroxy, nitro, amino, C1-C4 alkyl, C1-C4 alkylcarboxyl, C1-C4 alkylcarbonyl, C1-C4 alkoxy or C1-C4 thioalkoxy; R8 is C1-C4 alkyl; Y is oxygen, sulphur, amino, substituted amino or C1-C4 thioalkyl; Z is C1-C4 alkoxy, C1-C4 alkyl, C1-C4 alkylamino or C1-C4 thioalkoxy; X1 and X2 are independently carbon or nitrogen; and -N--C- and -C--Y- may form a single bond or a double bond provided that if -N--C- forms a single bond, -C--Y- forms a double bond, and if -C--Y- forms a single bond, -N--C- forms a double bond and R8 is nonexistent.

Description: Piperazine derivatives and process for the preparation thereof The present invention relates to a new piperazine derivative of the general formula (I) or its pharmaceutically acceptable acid addition salt, and process for the preparation thereof. (I) wherein Ri and R 2 are independently hydrogen, d-C alkyl, C1-C4 alkylcarboxyl, G-C 4 alkylcarbonyl, C1-C4 alkoxy, C1-C4 hydroxyalkyl, C1-C4 aminoalkyl or C1-C4 hydroxyiminoalkyl, or Ri and R2 are fused to form C3-C4 unsaturated ring; R3, R4, R5, RΘ and R7 are independently hydrogen, halogen, hydroxy, nitro, amino, C1-C4 alkyl, C1-C4 alkylcarboxyl, Cι-C alkylcarbonyl, C1-C4 alkoxy or C1-C4 thioalkoxy; R 8 is Q-C4 alkyl; Y is oxygen, sulphur, amino, substituted amino or G ~ C thioalkyl; Z is C1-C4 alkoxy, C1-C4 alkyl, C1-C4 alkylamino or C1-C4 thioalkoxy; Xi and X2 are independently carbon or nitrogen; and —N-C— and — C-Y — may form a single bond or a double bond provided that if — N ~ C— forms a single bond, — C-Y — forms a bouble bond, and if — C-Y — forms a single bond, —N-C— forms a bouble bond and Rs is nonexistent. In the above definitions, G-C 4 alkyl means methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl or tert-butyl. C1-C4 alkylcarboxyl means carboxyl esterified with a lower alkyl such as methylcarboxyl and ethylcarboxyl. C1-C4 alkylcarbonyl means carbonyl ketonized with a lower alkyl such as methylcarbonyl and ethylcarbonyl. Ci-C 4 alkoxy means methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy or tert-butoxy. C1-C4 thioalkoxy means methylthio, ethylthio, propylthio, isopropylthio, butylthio, isobutylthio or tert-butylthio. C1-C4 aminoalkyl means aminomethyl, aminoethyl, aminopropyl, aminobutyl or the like. Cι-C kydroxyalkyl means hydroxymethyl, hydroxyethyl, hydroxypropyl, hydroxybutyl or the like. C1-C4 hydroxyiminoalkyl means C1-C4 alkyl substituted with hydroxyimino such as hydroxyiminoethyl. Substituted amino means hydroxyamino, C1-C4 alkylamino, C1-C4 alkoxyamino or the like. The present inventors had studied for a long time to find compounds having intensive antitumor activity. As a result, now we have finally found out the facts that the present compounds of the general formula (I) and acid addition salts thereof have not only prominent antitumor activities but very low toxicities. Accordingly, the one object of the present invention is to provide the novel compounds of the general formula (I) and acid addition salts thereof having not only prominent antitumor activities but very low toxicities. The other object of the present invention is to provide a process for the preparation of the compounds of general formula(I) and acid addition salts thereof. The compounds of the present invention can be mixed with pharmaceutically acceptable vehicles by a known method to give pharmaceutical compositions and thus the pharmaceutical compositions can be used to prevent or treat with various kinds of tumors of human beings or mammals. Therefore, another object of the present invention is to provide pharmaceutical compositions containing the compound of the general formula(I) or an acid addition salt thereof as an active ingredient. Acids which can be reacted with the compounds of the general formula(I) to form acid addition salts are pharmaceutically acceptable inorganic or organic acids; for example, inorganic acids such as hydrochloric acid, bromic acid, sulfuric acid, phosphoric acid, nitric acid; organic acids such as formic acid, acetic acid, propionic acid, succinic acid, citric acid, maleic acid, malonic acid, gly colic acid, lactic acid; amino acids such as glycine, alanine, valine, leucine, isoleucine, serine, cysteine, cystine, asparaginic acid, glutamic acid, lysine, arginine, tyrosine, proline! sulfonic acids such as methane sulfonic acid, ethane sulfonic acid, benzene sulfonic acid, toluene sulfonic acid; or the like. Vehicles which can be used in the preparation of pharmaceutical compositions containing the compound of the general formula (I) as the active ingredient may include a sweetening agent, binding agent, dissolving agent, aids for dissolution, wetting agent, emulsifying agent, isotonic agent, adsorbent, degrading agent, antioxident, antiseptics, lubricating agent, filler, perfume or the like; such as lactose, dextrose, sucrose, mannitol, sorbitol, cellulose, glycine, silica, talc, stearic acid, stearin, magnesium stearate, calcium stearate, magnesium aluminum silicate, starch, gelatine, tragacanth gum, glycine, silica, alginic acid, sodium alginate, methyl cellulose, sodium carboxy methyl cellulose, agar, water, ethanol, polyethylenglycol, polyvinyl pyrrolidone, sodium chloride, potassium chloride, orange essence, strawberry essence, vanila aroma or the like. Daily dosage of the compound of the general formula (I) may be varied depending on age, sex of a patient, degree of disease, etc. and generally l.Omg to 5,000mg per day may be administered one to several times. The compounds of the general formula (I) according to the present invention wherein — N ~ c— forms a single bond and — C ~ Y — forms a bouble bond, may be prepared by the following scheme I. Scheme I (2) (3) wherein Ri, R 2 , R3, R4, R5, Re, R7, Rs, Xi, X2, Y and Z are as defined above, and Lie is a conventional leaving group such as halogen, sulfonyl or the like. The above process comprises reacting a compound of the general formula (2) with a -C(=Y)- group-providing agent in an organic solvent to obtain a compound of the general formula (3) and successively reacting the compound of the formula (3) with a compound of the general formula (4) to give the compound of the general formula (5). Then, the compound of the formula (5) may be reacted with an alkylating agent or an arylating agent in the presence of a base to give a compound of the general formula (la). The -C(=X) -group-providing agent used in the above reaction may include 1,1-carbonyldiimidazole, 1,1-carbonylthiodiimidazole, phosgene, thiophosgene, carbonyldiphenoxide and phenylchloroformate, and it may be used in an amount of 1 - 1.5 equivalent, preferably 1-1.1 equivalent to the starting compound. The reaction may be carried out in a conventional organic solvent such as, for example, tetrahydrofuran, dichloromethane, acetonitrile, chloroform and dimethylformamide. And also the reaction is preferably carried out in the presence of a coupling agent such as a conventional inorganic or an organic base. Such conventional inorganic or organic bases used in the reaction may include sodium hydride, potassium hydride, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, cesium carbonate, sodium bicarbonate, potassium bicarbonate, triethylamine, pyridine and DBU. The reaction may be carried out at a temperature between 3 ° C and boiling point of the solvent used, preferably at 50 ° C -100 ° C and for 5 - 48 hours, preferably for 10 - 24 hours. The reaction of the compound (3) with the compound (4) to give the compound (5) may be carried out in the presence of a conventional organic solvent at the temperature of 50-100°C for 5-48 hours. The compound (4) may be used by 1-1.5 equivalent. And also the reaction is preferably carried out in the presence of a conventional inorganic or organic base, such as sodium hydride, potassium hydride, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, cesium carbonate, sodium bicarbonate, potassium bicarbonate, triethylamine, pyridine, DBU or the like. Then, the compound of the formula (5) may be reacted with an alkylating agent or an arylating agent in the presence of a conventional organic or inorganic base to give a compound of the general formula (la). The alkylating agent and arylating agent used in the above step may include Ci-Cβ alkylhalide, Ci-Cβ alkylsulfonate, substituted or unsubstituted C3-C8 cycloalkyl halide, arylhalide, and substituted or unsubstituted C3-C8 cycloalkyl sulfonate. Ci-Cβ alkyl halide means methyl chloride, methyl bromide, methyl iodide, ethyl chloride, ethyl bromide, ethyl iodide, propyl chloride, propyl bromide, propyl iodide, butyl chloride, butyl bromide, butyl iodide, pentyl chloride, pentyl bromide, pentyl iodide, bromo ehtylacetate or the like. Ci-Cβ alkylsulfonate means methyl sulfonate, ethyl sulfonate, propyl sulfonate, butyl sulfonate, pentyl sulfonate or the like. Substituted or unsubstituted C3-C8 cycloalkyl halides mean cyclopropyl chloride, cyclopropyl bromide, cyclopropyl iodide, cyclobutyl chloride, cyclobutyl bromide, cyclobutyl iodide, cyclopentyl chloride, cyclopentyl bromide, cyclopentyl iodide, cyclohexyl chloride, cyclohexyl bromide, cyclohexyl iodide, cyclopropyl methyl chloride, cyclopropyl methyl bromide, cyclopropyl methyl iodide, cyclobutyl methyl chloride, cyclobutyl methyl bromide, cyclobutyl methyl iodide, cyclopentyl methyl chloride, cyclopentyl methyl bromide, cyclopentyl methyl iodide, cyclohexyl methyl chloride, cyclohexyl methyl bromide, cyclohexyl methyl iodide, or the like. Aryl halides may include benzyl chloride, benzyl bromide, benzyl iodide, benzoyl chloride, benzoyl bromide, benzoyl iodide, toluyl chloride, toluyl bromide and toluyl iodide. Substituted or unsubstituted C3-C8 cycloalkyl sulfonate may include cyclopropyl sulfonate, cyclobutyl sulfonate, cyclopentyl sulfonate, cyclohexyl sulfonate, cyclopropyl methyl sulfonate, cyclobutyl methyl sulfonate, cyclopentyl methyl sulfonate and cyclohexyl methyl sulfonate. Aryl sulfonate may include benzyl sulfonate, benzoyl sulfonate, toluyl sulfonate, or the like. The reaction may be carried out in a conventional organic solvent as such as, for example, tetrahydrofuran, dichloromethane, chloroform, dimethyl sulfoxide, acetonitrile and dimethylformamide. The conventional inorganic or organic base used in above step may include sodium hydride, potassium hydride, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, cesium carbonate, sodium bicarbonate, potassium bicarbonate, triethylamine, pyridine and DBU. In the above reaction process, if any acid material is formed, a basic material may be added as a scavenger in order to eliminate the acid material from the reaction phase. Such basic material may be alkali metal hydroxide, alkali earth metal hydroxide, alkali metal oxide, alkali earth metal oxide, alkali metal carbonate, alkali earth metal carbonate, alkali metal hydrogen carbonate, alkali earth metal hydrogen carbonate such as for example, sodium hydroxide, potassium hydroxide, calcium hydroxide, magnesium hydroxide, magnesium oxide, calcium oxide, potassium carbonate, sodium carbonate, calcium carbonate, magnesium carbonate, magnesium bicarbonate, sodium bicarbonate, calcium bicarbonate or the like, and organic amines. The compounds of the general formula (2) and the formula (4) are known compounds, or may be prepared by a known method described in, for example, Farmaco(pavia) Ed, Sci., 18(8), 557-65(1963) or by a similar method thereto. A compound of the general formula (I) wherein — C-Y — forms a single bond and —N-C— forms a double bond may be prepared by the following scheme II Scheme II. (II) ( X) (lb) wherein Ri, R 2 , R3, R4, R5, Re, R7, Xi, X2, Y and Z are as defined above, and R λ is lower alkyl such as methyl and ethyl. A compound of the general formula (II), which may be prepared by a known method, is reacted with an alkylating agent in the presence of a base to give a compound of the general formula (D. Then, the compound of the formula (D is reacted with a substituted or unsubstitued amine in the presence of a base to give a compound of the general formula (lb). The reaction may be carried out at a temperature between 3 ° C and boiling point of the solvent used, preferably at 50°C -100 ° C for 5 - 48 hours, preferably for 10 - 24 hours. The alkylating agent may be used in an amount of 1 - 1.5 equivalent to the compound (II). The alkylating agent may include Ci-Cs alkyl halide, Ci-Cs alkylsulfonate, substituted or unsubstituted C3-C8 cycloalkyl halide, aryl halide and substituted or unsubstituted C3-C8 cycloalkyl sulfonate. The reaction may be carried out in a conventional organic solvent as described above. The conventional inorganic or organic base as described above may be used in the above process. The compound of the formula (D is reacted with a substituted or unsubstitued amine in the presence of a conventional base to give a compound of the general formula (lb). The reaction also may be preferably carried out in a conventional organic solvent as decribed above. The conventional inorganic or organic base described above may be used in the above reaction step. In the above reactions, if any acid material is formed, any basic material may be preferably added as a scavenger in order to eliminate the acid material from the reaction phase. Such basic material may be the organic or inorganic bases as described in the scheme I above. The compound of the general formula (II) is a known compound, or may be prepared by a known method described in, for example, USP 5,780,472, PCT/KR97/00128 or by a similar method thereto. Hereinafter the present invention will be described in more details with reference to following examples but it is not intended to limit the scope of the invention thereinto. Compounds of the general formula (la) were prepared in following examples according to the above-mentioned process. (la) wherein Ri, R2, R3, R4, Rs, Re, R7, Rs, Xi, X2, Y and Z are as defined above. The compounds of the general formula (lb) were prepared in the following examples according to the above-described process. (lb) wherein, Ri, R2, R3, R4, Rs, Re, R7, X, Y and Z are as defined above. Example 1) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminocarbonyl]-4-phenylpiperazi ne a) Phenyl N-(5,6--dimethyl-2-methoxypyrazin-3-yl)carbamate: 3-Amino-5,6-dimethyl-2-methoxypyrazine(1.00g, 6.53mmol) and phenylchloroformate(1.02g, 6.53mmol) were dissolved in dichloromethane and stirred at room temperature for 2 hours. The resulting mixture was concentrated under the reduced pressure to remove the solvent and purified by column chromatography to obtain the titled compound, yield: 98 % m.p.: 101 - 103 °C b) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminocarbonyl]-4-phenyl piperazine: Phenyl N-(5,6-dimethyl-2-methoxypyrazin-3-yl)carbamate (350mg, 1.28mmol) and l-phenylpiperazine(208mg, 1.28mmol) were dissolved in anhydrous tetrahydrofuran and thereto DBU(195mg, 1.28mmol) was added. The resulting mixture was stirred at room temperature for 2 hours and concentrated under the reduced pressure to remove the solvent, and purified by column chromatography to obtain the titled compound, yield : 78.5% m.p. : 185- 187 ° C Example 2) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminocarbonyl]-4- (2~methoxyphenyl)piperazine Phenyl N-(5,6-dimethyl-2-methoxypyrazin-3-yl)carbamate and l-(2-methoxyphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield: 82.0% m.p.: 184~185 ° C Example 3) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminocarbonyl]-4- (3,5-dimethoxyphenyl)piperazine Phenyl N-(5,6-dimethyl-2-methoxypyrazin-3-yl)carbamate and l-(3,5-dimethoxyphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield: 85.0% m.p.: 136~ 137 °C Example 4) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminocarbonyl]-4- (2-ethylphenyl)piperazine Phenyl N-(5,6-dimethyl-2-methoxypyrazin-3-yl)carbamate and l-(2-ethylphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield: 70.4% m.p.: 197- 199 ° C Example 5) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminocarbonyl]-4- (4-butylphenyl )piperazine Phenyl N-(5,6-dimethyl-2-methoxypyrazin-3-yl)carbamate and l-(4-butylphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield: 68.5% m.p.: 121 - 123 °C Example 6) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminocarbonyl]-4- (2-isopropylphenyl)piperazine Phenyl N-(5,6-dimethyl-2-methoxypyrazin-3-yl)carbamate and l-(2-isopropylphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield: 73.0% m.p.: 165- 167 °C Example 7) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminocarbonyl]-4- (3,5-dimethylphenyl)piperazine Phenyl N-(5,6-dimethyl-2-methoxypyrazin-3-yl)carbamate and l-(3,5-dimethylphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield: 84.0% m.p.: 162- 164 ° C Example 8) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminocarbonyl]-4- (2,3,5,6-tetramethylphenyDpiperazine Phenyl N-(5,6-dimethyl-2-methoxypyrazin-3-yl)carbamate and l-(2,3,5,6,-tetramethylphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield: 65.5% m.p.: 202- 204 °C Example 9) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminocarbonyl]-4- (2-fluorophenyl)piperazine Phenyl N-(5,6-dimethyl-2-methoxypyrazin-3-yl)carbamate and l-(2-fluorophenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield: 74.5% m.p.: 170- 172 ° C Example 10) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminocarbonyl]-4- (3-bromophenyl)piperazine Phenyl N-(5,6-dimethyl-2-methoxypyrazin-3-yl)carbamate and l-(3 ~ bromophenyDpiperazine were reacted by the same way with the example 1 to obtain the titled compound. yield: 70.0% m.p.: 158~ 160 ° C Example 11) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminocarbonyl]-4- (3,5-dichlorophenyl)piperazine Phenyl N-(5,6-dimethyl-2-methoxypyrazin-3-yl)carbamate and l-(3,5-dichlorophenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield: 80.5% m.p.: 180~ 181 °C Example 12) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminocarbonyl]-4- (3,5-difluorophenyl)piperazine Phenyl N-(5,6-dimethyl-2-methoxypyrazin-3-yl)carbamate and l-(3,5-difluorophenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield: 78.0% m.p.: 153- 154 ° C Example 13) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminocarbonyl]-4- (3-trifluorotolyl)piperazine Phenyl N-(5,6-dimethyl-2-methoxypyrazin-3-yl)carbamate and l-(3-trifluorotolyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield: 69.5% m.p.: 168- 170 °C Example 14) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminocarbonyl]-4- ( 2-methy lthiopheny 1 )piperazine Phenyl N-(5,6-dimethyl-2-methoxypyrazin-3-yl)carbamate and 1- (2-methy IthiophenyDpiperazine were reacted by the same way with the example 1 to obtain the titled compound. yield: 71.0% m.p.: 202- 204 °C Example 15) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminocarbonyl]-4- (3,5-dinitrophenyl)piperazine Phenyl N-(5,6-dimethyl-2-methoxypyrazin-3-yl)carbamate and l-(3,5-dinitrophenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield: 64.5% m.p.: 192- 194 ° C Example 16) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminocarbonyl]-4- (3,5-diaminophenyl)piperazine l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminocarbonyl]-4- (3,5-dinitrophenyl)piperazine was dissolved in ethanol(30ml) and thereto 10% palladium/carbondOmg) was added. The resulting mixture was hydrogenated for 4 hours, and then filtered to remove the 10% palladium/carbon. The filtrate was concentrated and purified by column chromatography to obtain the titled compound. yield : 45.0% m.p.: > 100 ° C (decomposed) Example 17) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminocarbonyl]-4- (4-acetylphenyl)piperazine Phenyl N-(5,6-dimethyl-2-methoxypyrazin-3-yl)carbamate and l-(4-acetylphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. Yield : 71.5% m.p.: 166- 168 ° C Example 18) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl) N-methylamino- carbonyl] -4- (2-methoxyphenyl)piperazine 1 - [(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminocarbonyl] -4- (2-methoxyphenyl)piperazine(200mg, 0.54mmol) was dissolved in dimethylformamide (15ml) and thereto 60% sodium hydride (21.5mg, 0.54mmol) was added. The resulting mixture was stirred at room temperature for 15 minutes, and thereto methyl iodide(76.6mg, 0.54mmol) was added. The resulting mixture was stirred at room temperature for 6 hours, concentrated under the reduced pressure to remove the solvent, and purified by column chromatography to obtain the titled compound. yield: 92.5% m.p.: 140- 142 °C Example 19) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl) N-methylamino- carbonyl] -4- (3,5-dimethoxyphenyl)piperazine l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminocarbonyl]-4- (3,5-dimethoxyphenyl)piperazine was reacted by the same way with the example 18 to obtain the titled compound. yield: 90.5% m.p.: 80~82 ° C Example 20) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl) N-methylamino- carbonyl] -4- (3,5-dimethylphenyl)piperazine l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminocarbonyl]-4- (3,5-dimethylphenyl)piperazine was reacted by the same way with the example 18 to obtain the titled compound. yield: 88.4% m.p.: 94-96°C Example 21) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl) N-methylamino- carbonyl] -4- (3,5-dichlorophenyl)piperazine 1 - [(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminocarbonyl] -4- (3,5-dichlorophenyl)piperazine was reacted by the same way with the example 18 to obtain the titled compound. yield: 95.2% m.p.: 97-99 ° C Example 22) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl) N-methylamino- carbonyl] -4- (3,5-difluorophenyl)piperazine l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminocarbonyl]-4- (3,5-difluorophenyl)piperazine was reacted by the same way with the example 18 to obtain the titled compound. yield: 94.0% m.p.: 104- 106 °C Example 23) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl) N-methylamino - carbonyl] -4- (2-methylthiophenyl)piperazine 1 - [(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminocarbonyl] -4- (2-methylthiophenyl)piperazine was reacted by the same way with the example 18 to obtain the titled compound. yield: 89.5% m.p.: 133- 134 ° C Example 24) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl) N-methylamino- carbonyl] -4- (3,5-dinitrophenyl)piperazine l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminocarbonyl]-4- (3,5-dinitrophenyl)piperazine was reacted by the same way with the example 18 to obtain the titled compound. yield: 80.0% m.p.: 133- 135 ° C Example 25) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl) N-methylamino- carbonyl] -4- (3,5-diaminophenyl)piperazine l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl)N-methylaminocarbonyl]-4- (3,5-dinitrophenyl)piperazine was reacted by the same way with the example 18 to obtain the titled compound. yield: 58.5% m.p.: > 100 ° C (decomposed) Example 26) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl) N-ethylamino- carbonyl] -4- (3,5-dimethoxyphenyl)piperazine l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminocarbonyl]-4- (3,5-dimethoxyphenyl)piperazine(250mg, 0.62mmol) was dissolved in dimethylformamide(20ml) and thereto 60% sodium hydride(24.9mg, 0.62mmol) was added. The mixture was stirred at room temperature for 15 minutes, and thereto methyl iodide(96.7mg, 0.62mmol) was added. The resulting mixture was stirred at room temperature for 6 hours, concentrated under the reduced pressure to remove the solvent used, and purified by column chromatography to obtain the titled compound. yield: 89.5% m.p.: 78~80°C Example 27) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl) N-ethylamino- carbonyl]-4-(3,5-dimethylphenyl)piperazine l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminocarbonyl]-4- (3,5-dimethylphenyl)piperazine was reacted by the same way with the example 26 to obtain the titled compound, yield: 92.0% m.p.: 68~70 ° C Example 28) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl)arninothiocarbonyl]-4- (3,5-dimethoxyphenyl)piperazine a) Phenyl N-(5,6-dimethyl-2-methoxypyrazin-3-yl)thiocarbamate: 3-Amino-5,6-dimethyl-2-methoxypyrazine(500mg, 3.26mmol) was dissolved in dichloromethane and thereto phenyl thiochloroformate (564mg, 3.26mmol) was slowly added. The mixture was stirred at room temperature for 24 hours, concentrated under the reduced pressure to remove the solvent, and purified by column chromatography to obtain the titled compound. yield: 78.5% m.p.: 71 ~73 ° C b) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminothiocarbonyl]-4- (3,5-dimethoxyphenyl)piperazine: Phenyl N-(5,6-dimethyl-2-methoxypyrazin-3-yl)thiocarbamate (200mg, 0.69mmol) and l-(3,5-dimethoxyphenyl)piperazine(154mg, 0.69mmol) were dissolved in anhydrous tetrahydrofuran(25ml) and thereto DBU(105mg, 0.69mmol) was added. The mixture was stirred at room temperature for 2 hours, concentrated under the reduced pressure to remove the solvent and purified by column chromatography to obtain the titled compound. yield : 71.5% m.p. : 183- 184 ° C Example 29) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminothiocarbonyl]-4- (2-ethylphenyl)piperazine Phenyl N-(5,6-dimethyl-2-methoxypyrazin-3-yl)thiocarbamate and l-(2-ethylphenyl)piperazine were reacted by the same way with the example 28 to obtain the titled compound. yield: 64.0% m.p.: 197- 199 ° C Example 30) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminothiocarbonyl]-4- (3,5-dimethylphenyl)piperazine Phenyl N-(5,6-dimethyl-2-methoxypyrazin-3-yl)thiocarbamate and l-(3,5-dimethylphenyl)piperazine were reacted by the same way with the example 28 to obtain the titled compound. yield: 68.4% m.p.: 160~162°C Example 31) 1- [(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminothiocarbonyl] -4- (3-bromophenyl)piperazine Phenyl N-(5,6-dimethyl-2-methoxypyrazin-3-yl)thiocarbamate and l-(3-bromophenyl)piperazine were reacted by the same way with the example 28 to obtain the titled compound. yield: 62.5% m.p.: 136-138 ° C Example 32) 1- [(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminothiocarbonyl] -4- (3,5-dichlorophenyl)piperazine Phenyl N-(5,6-dimethyl-2-methoxypyrazin-3-yl)thiocarbamate and l-(3,5-dichlorophenyl)piperazine were reacted by the same way with the example 28 to obtain the titled compound. yield: 70.8% m.p.: 182- 184 °C Example 33) l-[(5,6-Dimethyl-2-methoxypyrazin-3-yl)aminothiocarbonyl]-4- (2-methylthiophenyl)piperazine Phenyl N-(5,6-dimethyl-2-methoxypyrazin-3-yl)thiocarbamate and l-(2-methylthiophenyl)piperazine were reacted by the same way with the example 28 to obtain the titled compound. yield: 61.4% m.p.: 181 - 183 ° C Example 34) l-[(5,6-Dichloroethyl-2-methoxypyrazin-3-yl)aminocarbonyl]-4- (3,5-dimethylphenyl)piperazine Phenyl N-(5,6-diethyl-2-methoxypyrazin-3-yl)carbamate and l-(3,5-dimethylphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield: 77.5% m.p.: 118- 1201: Example 35) l-[(5,6-Dichloroethyl-2-methoxypyrazin-3-yl)aminocarbonyl]-4- (3,5-dimethoxyphenyl)piperazine Phenyl N-(5,6-diethyl-2-methoxypyrazin-3-yl)carbamate and l-(3,5-dimethoxyphenyl)piperazine were reacted by the same way with the example 1 to obtain the titled compound. yield: 78.9% m.p.: 90~92 ° C Example 36) l-[(2-Methoxyquinoxalin-3-yl)aminocarbonyl]-4-phenylpiperazine a) Phenyl N-(2-methoxyquinoxalin-3-yl)carbamate: 3-Amino-2-methoxyquinoxaline(1.00g, 6.53mmol) and phenylchloroformate (1.02g, 6.53mmol) were dissolved in dichloromethane and stirred at room temperature for 2 hours. The resulting mixture was concentrated under the reduced pressure to remove the solvent, and purified by column chromatography to obtain the titled compound. yield: 75.5% m.p.: 147- 149 ° C b) l-[(2-Methoxyquinoxalin-3-yl)aminocarbonyl]-4-phenylpiperazine: Phenyl N-(2-methoxyquinoxalin-3-yl)carbamate(378mg, 1.28mmol) and l-phenylpiperazine(208mg, 1.28mmol) were dissolved in anhydrous tetrahydrofuran and thereto DBU(195mg, 1.28mmol) was added. The mixture was stirred at room temperature for 2 hours, concentrated under the reduced pressure to remove the solvent, and purified by column chromatography to obtain the titled compound. yield : 76.5% m.p. : 156- 158 °C Example 37) 1 - [(2-Methoxyquinoxalin-3-yl)aminocarbonyl] -4- (2-methoxyphenyl)- piperazine Phenyl N-(2-methoxyquinoxalin-3-yl)carbamate and l-(2-methoxyphenyl)piperazine were reacted by the same way with the example 36 to obtain the titled compound. yield : 72.4% m.p. : 177~ 178°C Example 38) l-[(2-MethoxyquinoxaUn-3-yl)aιmnocarbonyl]-4-(3,5-dimethoxyphenyl) piperazine Phenyl N-(2-methoxyquinoxalin-3-yl)carbamate and l-(3,5-dimethoxy-phenyl)piperazine were reacted by the same way with the example 36 to obtain the titled compound. yield : 81.2% m.p. : 140- 141°C Example 39) l-[(2-Methoxyquinoxalin-3-yl)aminocarbonyl]-4-(2-ethylphenyl)piperazine Phenyl N-(2-methoxyquinoxalin-3-yl)carbamate and l-(2-ethylphenyl)piperazine were reacted by the same way with the example 36 to obtain the titled compound. yield : 75.0% m.p. : 191 - 193 ° C Example 40) l-[(2-Methoxyquinoxalin-3-yl)aminocarbonyl]-4-(2-isoprop-ylphenyl) piperazine Phenyl N-(2-methoxyquinoxalin-3-yl)carbamate and l-(2-isopropylphenyl)piperazine were reacted by the same way with the example 36 to obtain the titled compound. yield : 77.5% m.p. : 147- 149 ° C Example 41) 1- [(2-Methoxyquinoxalin-3-yl)aminocarbonyl]-4- (4-butylph-enyl)- piperazine Phenyl N-(2-methoxyquinoxalin-3-yl)carbamate and l-(4-butylphenyl)-piperazine were reacted by the same way with the example 36 to obtain the titled compound. yield : 65.4% m.p. : 124- 126 ° C Example 42) l-[(2-Methoxyquinoxalin-3-yl)aminocarbonyl]-4-(3,5-dimethylphenyl) piperazine Phenyl N-(2-methoxyquinoxalin-3-yl)carbamate and l-(3,5-dimethylphenyl)piperazine were reacted by the same way with the example 36 to obtain the titled compound. yield : 79.3% m.p. : 155- 157 ° C Example 43) l-[(2-Methoxyquinoxalin-3-yl)aminocarbonyl]-4-(2,3,5,6-tetramethyl- phenyDpiperazine Phenyl N-(2-methoxyquinoxalin-3-yl)carbamate and l-(2,3,5,6-tetramethylphenyl)piperazine were reacted by the same way with the example 36 to obtain the titled compound. yield : 64.0% m.p. : 237- 239 ° C Example 44) 1 - [(2-Methoxyquinoxalin-3-yl)aminocarbonyl] -4- (2-fluorop-henyl) piperazine Phenyl N-(2-methoxyquinoxalin-3-yl)carbamate and l-(2-fluorophenyl)-piperazine were reacted by the same way with the example 36 to obtain the titled compound. yield : 67.5% m.p. : 142- 144 ° C Example 45) l-[(2-Methoxyquinoxalin-3-yl)aminocarbonyl]-4-(3-bromop-henyl) piperazine Phenyl N-(2-methoxyquinoxalin-3-yl)carbamate and l-(3-bromophenyl) -piperazine were reacted by the same way with the example 36 to obtain the titled compound. yield : 69.5% m.p. : 148- 150 ° C Example 46) l-[(2-Methoxyquinoxalin-3-yl)aminocarbonyl]-4-(3,5-difluo-rophenyl) piperazine Phenyl N-(2-methoxyquinoxalin-3-yl)carbamate and l-(3,5-difluorophenyl)piperazine were reacted by the same way with the example 36 to obtain the titled compound. yield : 74.5% m.p. : 172- 173 ° C Example 47) l-[(2-Methoxyquinoxalin-3-yl)aminocarbonyl]-4-(2-trifluorotolyl) piperazine Phenyl N-(2-methoxyquinoxalin-3-yl)carbamate and l-(2-trifluorotolyl)-piperazine were reacted by the same way with the example 36 to obtain the titled compound. yield : 70.7% m.p. : 132- 134 °C Example 48) l-[(2-Methoxyquinoxalin-3-yl)aminocarbonyl]-4-(3,5-dinitrophenyl) piperazine Phenyl N-(2-methoxyquinoxalin-3-yl)carbamate and l-(3,5-dinitrophenyl)piperazine were reacted by the same way with the example 36 to obtain the titled compound. yield : 54.5% m.p. : 216- 218 ° C Example 49) 1 - [(2-Methoxyquinoxalin-3-yl)aminocarbonyl] -4- (3,5-diami-nophenyl) piperazine l-[(2-Methoxyquinoxalin-3-yl)aminocarbonyl]-4-(3,5-dinitrophenyl) piperazine(200mg, 0.44mmol) was dissolved in ethanol(30ml) and thereto 10% palladium/carbondOmg) was added. The mixture was hydrogenated for 4 hours, and then filtered to remove the 10% palladium/carbon. The filtrate was concentrated and purified by column chromatography to obtain the titled compound. Yield : 42.5% m.p.: >100 ° C (decomposed) Example 50) l-[(2-Methoxyquinoxalin-3-yl)aminocarbonyl]-4-(4-acetylp-henyl) piperazine Phenyl N-(2-methoxyquinoxalin-3-yl)carbamate and 1- (4- acetylphenyl) -piperazine were reacted by the same way with the example 36 to obtain the titled compound. yield : 71.0% m.p. : 198- 200 °C Example 51) 1- [(2-Methoxyquinoxalin-3-yl)aminocarbonyl]-4- (2-methylt-hiophenyl) piperazine Phenyl N-(2-methoxyquinoxalin-3-yl)carbamate and l-(2-methylthiophenyl)piperazine were reacted by the same way with the example 36 to obtain the titled compound. yield : 69.8% m.p. : 180- 182 ° C Example 52) l-[(2-Methoxyquinoxalin-3-yl)aminocarbonyl]-4-(2-biphen-yl)piperazine Phenyl N-(2-methoxyquinoxalin-3-yl)carbamate and l-(2-biphenyl)piperazine were reacted by the same way with the example 36 to obtain the titled compound. yield : 59.0% m.p. : 162- 165 ° C Example 53) l-[(2-Methoxyquinoxalin-3-yl) N-methylaminocarbonyl] -4- (3,5-dimethoxyphenyl)piperazine l-[(2-Methoxyquinoxalin-3-yl)aminocarbonyl]-4-(2-methoxyphenyl) piperazine(229mg, 0.54mmol) was dissolved in dimethylformamide(15ml) and thereto 60% sodium hydride(21.5mg, 0.54mmol) was added. The mixture was stirred at room temperature for 15 minutes, and thereto ehtyl iodide (76.6mg, 0.54mmol) was added. The mixture was stirred at room temperature for 6 hours, concentrated under the reduced pressure to remove the solvent and purified by column chromatography to obtain the titled compound. yield : 92.5% m.p. : 143- 144 ° C Example 54) l-[(2-Methoxyquinoxalin-3-yl) N-methylaminocarbonyl] -4- (2-methoxyphenyl)piperazine l-[(2-Methoxyquinoxalin-3-yl)aminocarbonyl]-4-(2-methoxyphenyl) piperazine was reacted by the same way with the example 53 to obtain the titled compound. yield : 83.8% m.p. : 128- 130 ° C Example 55) l-[(2-Methoxyquinoxalin-3-yl) N-methylaminocarbonyl] -4- (3,5-dimethylphenyl)piperazine l-[(2-Methoxyquinoxalin-3-yl)aminocarbonyl]-4-(3,5-dimethylphenyl) piperazine was reacted by the same way with the example 53 to obtain the titled compound. yield : 86.5% m.p. : 142- 144 ° C Example 56) l-[(2-Methoxyquinoxalin-3-yl) N-methylaminocarbonyl] -4- (3,5-difluorophenyl)piperazine l-[(2-Methoxyquinoxalin-3-yl)aminocarbonyl]-4-(3,5-difluorophenyl) piperazine was reacted by the same way with the example 53 to obtain the titled compound. yield : 84.7% m.p. : 197- 199 °C Example 57) l-[(2-Methoxyquinoxalin-3-yl) N-methylaminocarbonyl] -4- (3,5-dinitrophenyl)piperazine l-[(2-Methoxyquinoxalin-3-yl)aminocarbonyl]-4-(3,5-dinitrophenyl) piperazine was reacted by the same way with the example 53 to obtain the titled compound. yield : 56.5% m.p. : 197- 199 ° C Example 58) l-[(2-Methoxyquinoxalin-3-yl) N-methylaminocarbonyl] -4- (3,5-diaminophenyl)piperazine To l-[(2-methoxyquinoxalin-3-yl) N-methylaminocarbonyl] -4- (3,5-dinitrophenyl)piperazine dissolved in ethanol(30ml), 10% palladium/carbon (lOmg) was added. The mixture was hydrogenated for 4 hours, and then filtered to remove the 10% palladium/carbon. The filtrate was concentrated and purified by column chromatography to obtain the titled compound. Yield : 44.5% m.p.: >100 ° C (decomposed) Example 59) l-[(2-Methoxyquinoxalin-3-yl) N-ethylaminocarbonyl]-4- (3,5-dimethoxyphenyl)piperazine To l-[(2-methoxyquinoxalin-3-yl)aminocarbonyl]-4- (3,5-dimethoxyphenyl)piperazine(263mg, 0.62mmol) dissolved in dimethylformamide (20ml), 60% sodium hydride(24.9mg, 0.62mmol) was added and stirred at room temperature for 15 minutes, and thereto methyl iodide (96.7mg, 0.62mmol) was added. The resulting mixture was stirred at room temperature for 6 hours, concentrated under the reduced pressure to remove the solvent and purified by column chromatography to obtain the titled compound. yield : 85.4% m.p. : 129- 130 °C Example 60) l-[(2-Methoxyquinoxalin-3-yl) N-ethylaminocarbonyl]-4- (3,5-dimethylphenyl)piperazine l-[(2-Methoxyquinoxalin-3-yl)aminocarbonyl]-4-(3,5-dimethylphenyl) piperazine was reacted by the same way with the example 59 to obtain the titled compound. yield : 87.6% m.p. : 145- 147 °C Example 61) l-[(2-Methoxyquinoxalin-3-yl) N-ethylaminocarbonyl]-4- (3,5-dichlorophenyl)piperazine l-[(2-Methoxyquinoxalin-3-yl)aminocarbonyl]-4-(3,5-dichlorophenyl) piperazine were reacted by the same way with the example 59 to obtain the titled compound. yield : 80.6% m.p. : 146- 148 °C Example 62) l-[(2-Methoxyquinoxalin-3-yl) N-isopropylaminocarbonyl]- 4- (3,5-dimethoxyphenyl)piperazine To 1 - [(2-methoxyquinoxalin-3-yl)aminocarbonyl] -4- (3,5-dimethoxyphenyl)piperazine(216mg, O.δlmmol) dissolved in dimethylformamide(20ml), 60% sodium hydride(20.4mg, O.δlmmol) was added and stirred at room temperature for 15 minutes, and thereto propyl iodide (86.7mg, O.δlmmol) was added. The resulting mixture was stirred at room temperature for 6 hours, concentrated under the reduced pressure to remove the solvent and purified by column chromatography to obtain the titled compound. yield : 82.0% m.p. : 110- 112 °C Example 63) l-[(2-Methoxyquinoxalin-3-yl)aminothiocarbonyl]-4-(2-met-hoxyphenyl) piperazine a) Phenyl N-(2-Methoxyquinoxalin-3-yl)thiocarbamate: To 3-Amino-2-Methoxyquinoxaline(571mg, 3.26mmol) dissolved in dichloromethane, phenylthiochloroformate(δ64mg, 3.26mmol) were added slowly and stirred at room temperature for 24 hours. The resulting mixture was concentrated under the reduced pressure to remove the solvent and purified by column chromatography to obtain the titled compound. yield: 60.δ% m.p.: 160- 162 °C b) l-[(2-Methoxyquinoxalin-3-yl)aminothiocarbonyl]-4-(2-methoxyphenyl) piperazine: Phenyl N-(2-methoxyquinoxalin-3-yl)thiocarbamate(21δmg, 0.69mmol) and l-(2-methoxyphenyl)piperazine(lδ4mg, 0.69mmol) were dissolved in anhydrous tetrahydrofuran (2δml) and thereto DBUdOδmg, 0.69mmol) was added. The mixture was stirred at room temperature for 2 hours, concentrated under the reduced pressure to remove the solvent and purified by column chromatography to obtain the titled compound. yield : 62.4% δ m.p. : 177- 179 ° C Example 64) l-[(2-Methoxyquinoxalin-3-yl)aminothiocarbonyl]-4-(3,δ-dimethoxy- pheny 1 )piperazine Phenyl N-(2-methoxyquinoxalin-3-yl)thiocarbamate and 10 l"(3,δ-dimethoxyphenyl)piperazine were reacted by the same way with the example 63 to obtain the titled compound. yield : 64.δ% m.p. : 141 - 143 °C Example 6δ) lδ l-[(2-Methoxyquinoxalin-3-yl)aminothiocarbonyl]-4-(2-ethylphenyl) piperazine Phenyl N-(2-methoxyquinoxalin-3-yl)thiocarbamate and l-(2-ethylphenyl)piperazine were reacted by the same way with the example 63 to obtain the titled compound. 20 yield : 60.7% m.p. : 141 - 143 °C Example 66) l-[(2-Methoxyquinoxalin-3-yl)aminothiocarbonyl]-4-(3,δ-di-methyl- phenyDpiperazine 2δ Phenyl N-(2-methoxyquinoxalin-3-yl)thiocarbamate and l-(3,δ-dimethylphenyl)piperazine were reacted by the same way with the example 63 to obtain the titled compound. yield : 6δ.0% m.p. : 193~ 19δ°C 30 Example 67) l-[(2-Methoxyquinoxalin-3-yl)aminothiocarbonyl]-4-(3-bro-mophenyl) piperazine Phenyl N-(2-methoxyquinoxalin-3-yl)thiocarbamate and l-(3-bromophenyl)piperazine were reacted by the same way with the example 63 to obtain the titled compound. δ yield : δ7.δ% m.p. : 19δ~197 ° C Example 68) 1 - [(2-Methoxyquinoxalin-3-yl)aminothiocarbonyl] -4- (3,δ-difluorophenyl) piperazine 10 Phenyl N-(2-methoxyquinoxalin-3-yl)thiocarbamate and l-(3,δ-difluorophenyl)piperazine were reacted by the same way with the example 63 to obtain the titled compound. yield : δ9.0% m.p. : 280- 281 °C lδ Example 69) 1 - [ (2-Methoxyquinoxalin-3-yl)aminothiocarbonyl] -4- (2-methylthio- phenyDpiperazine Phenyl N-(2-methoxyquinoxalin-3-yl)thiocarbamate and 1- (2-methy IthiophenyDpiperazine were reacted by the same way with 20 the example 63 to obtain the titled compound. yield : 64.δ% m.p. : 148~ lδO°C Example 70) l-[(2-Methoxyquinoxalin-3-yl)aminothiocarbonyl]-4-(4-acetylphenyl) 2δ piperazine Phenyl N-(2-methoxyquinoxalin-3-yl)thiocarbamate and l-(4-acetylphenyl)piperazine were reacted by the same way with the example 63 to obtain the titled compound. yield : δ6.9% 30 m.p. : 235- 237 ° C Example 71) 1- [(2-Methoxyquinoxalin-3-yl)aminothiocarbonyl] -4- (4-but-ylphenyl) piperazine Phenyl N-(2-methoxyquinoxalin-3-yl)thiocarbamate and l-(4-butylphenyl)piperazine were reacted by the same way with the δ example 63 to obtain the titled compound. yield : 62.δ% m.p. : 163~16δ ° C Example 72) 1 - [(2-Ethoxyquinoxalin-3-yl)aminocarbonyl] -4- (3,5-dimethoxyphenyl) 10 piperazine Phenyl N-(2-ethoxyquinoxalin-3-yl)carbamate and l-(3,5-dimethoxyphenyl)piperazine were reacted by the same way with the example 36 to obtain the titled compound. yield : 74.7% lδ m.p. : 149~ lδO°C Example 73) 1 - [(2-Ethoxyquinoxalin-3-yl)aminocarbonyl] -4- (2-ethoxyphenyl) piperazine Phenyl N-(2-ethoxyquinoxalin-3-yl)carbamate and 20 l-(2-ethoxyphenyl)-piperazine were reacted by the same way with the example 36 to obtain the titled compound. yield : 76.δ% m.p. : 120- 122 °C Example 74) 25 l-[(2-Ethoxyquinoxalin-3-yl)armnocarbonyl]-4-(3,5-dimethylphenyl) piperazine Phenyl N-(2-ethoxyquinoxalin-3-yl)carbamate and l-(3,δ-dimethylphenyl)piperazine were reacted by the same way with the example 36 to obtain the titled compound. 30 yield : 82.0% m.p. : lδ2-lδ4°C Example 75) l-[(2-Ethoxyquinoxalin-3-yl)aminocarbonyl]-4-(2,3-dimethylphenyl) piperazine Phenyl N-(2-ethoxyquinoxalin-3-yl)carbamate and δ l-(2,3-dimethylphenyl)piperazine were reacted by the same way with the example 36 to obtain the titled compound. yield : 78.7% m.p. : 108~110°C Example 76) 10 l-[(2-Ethoxyquinoxalin-3-yl)aminocarbonyl]-4-(2-ethylphenyl)piperazine Phenyl N-(2-ethoxyquinoxalin-3-yl)carbamate and l-(2-ethylphenyl)piperazine were reacted by the same way with the example 36 to obtain the titled compound. yield : 77.δ% lδ m.p. : lδ2~154°C Example 77) 1 - [ (2-Ethoxyquinoxalin-3-yl)aminocarbonyl] -4- (3,5-dichlorophenyl) piperazine Phenyl N-(2-ethoxyquinoxalin-3-yl)carbamate and 20 l-(3,δ-dichlorophenyl)piperazine were reacted by the same way with the example 36 to obtain the titled compound. yield : 81.3% m.p. : lδ7~lδ9°C Example 78) 2δ 1 - [(2-Ethoxyquinoxalin-3-yl)aminocarbonyl] -4- (3-bromophenyl)piperazine Phenyl N-(2-ethoxyquinoxalin-3-yl)carbamate and l-(3-bromophenyl)-piperazine were reacted by the same way with the example 36 to obtain the titled compound. yield : 80.6% 30 m.p. : 164- 166 °C Example 79) 1 - [ ( 2-Ethoxyquinoxalin-3-yl)aminocarbonyl] -4- (3,δ-difluorophenyl) piperazine Phenyl N-(2-ethoxyquinoxalin-3-yl)carbamate and l-(3,δ-difluorophenyl)piperazine were reacted by the same way with the δ example 36 to obtain the titled compound. yield : 78.6% m.p. : 146- 148 °C Example 80) l-[(2-Ethoxyquinoxalin-3-yl)aminocarbonyl]-4-(2-methylthiophenyl) 10 piperazine Phenyl N-(2-ethoxyquinoxalin-3-yl)carbamate and 1- (2-methy IthiophenyDpiperazine were reacted by the same way with the example 36 to obtain the titled compound. yield : 71.4% lδ m.p. : 139~ 141°C Example 81) l-[(2-Ethoxyquinoxalin-3-yl) N-methylaminocarbonyl] -4- (3,δ-dimethoxyphenyl)piperazine 1 - [(2-Ethoxyquinoxalin-3-yl)aminocarbonyl] -4- (3,δ-dimethoxyphenyl)- piperazine was reacted by the same way with the example δ3 to obtain 20 the titled compound. yield : 92.8% m.p. : 159- 161 Example 82) l-[(2-Ethoxyquinoxalin-3-yl) N-methylaminocarbonyl] -4- (3,δ-dichlorophenyl)piperazine 2δ l-[(2-Ethoxyquinoxalin-3-yl)aminocarbonyl]-4-(3,δ-dichlorophenyl) piperazine was reacted by the same way with the example δ3 to obtain the titled compound. yield : 94.δ% m.p. : 129- 1311 30 Example 83) l-[(2-Ethoxyquinoxalin-3-yl) N-ethylaminocarbonyl]-4- ( 3 ,δ - dimethoxypheny 1 )piperazine 1 - [(2-Ethoxyquinoxalin-3-yl)aminocarbonyl] -4- (3,δ-dimethoxyphenyl) - piperazine was reacted by the same way with the example 61 to obtain the titled compound. yield : 82.8% δ m.p. : 144- 146 ° C Example 84) l-[(2-Ethoxyquinoxalin-3-yl) N-ethylaminocarbonyl]-4- (3,δ-dichlorophenyl)piperazine l-[(2-Ethoxyquinoxalin-3-yl)aminocarbonyl]-4-(3,δ-dichlorophenyl) piperazine was reacted by the same way with the example 61 to obtain 0 the titled compound. yield : 80.7% m.p. : 115- 117 °C Example 85) l-[(2-Ethoxyquinoxalin-3-yl) N-ethylaminocarbonyl]-4- (3,δ-dimethylphenyl)piperazine 5 l-[(2-Ethoxyquinoxalin-3-yl)arninocarbonyl]-4-(3,5-dimethylphenyl)- piperazine was reacted by the same way with the example 61 to obtain the titled compound. yield : 78.8% m.p. : 142- 144 ° C 0 Example 86) l-[(2-Methoxynaphth-3-yl)aminocarbonyl]-4-(3,δ-dimethylphenyl)- piperazine a) Phenyl N-(2-methoxynaphth-3-yl)carbamate: 3-Amino-2-methoxynaphthalene(1.13g, 6.δ3mmol) and δ phenylchloroformate(1.02g, 6.δ3mmol) were dissolved in dichloromethane. The mixture was stirred at room temperature for 2 hours, concentrated under the reduced pressure to remove the solvent and purified by column chromatography to obtain the titled compound, yield: 75.0% 0 m.p.: 105- 107 °C b) l-[(2-Methoxynaphth-3-yl)aminothiocarbonyl]-4-(3,δ-dimethylphenyl- piperazine: Phenyl N-(2-methoxynaphth-3-yl)carbamate(37δmg, 1.28mmol) and l-(3,δ-dimethylphenyl)piperazine(208mg, 1.28mmol) were dissolved in anhydrous tetrahydrofuran(2δml) and thereto DBU(19δmg, 1.28mmol) δ was added, and then stirred at room temperature for 2 hours, concentrated under the reduced pressure to remove the solvent and purified by column chromatography to obtain the titled compound. yield : 72.0% m.p. : 117- 119 ° C 10 Example 87) l-[(2-Methoxynaphth-3-yl)aminocarbonyl]-4-(3,δ-dimethoxyphenyl) piperazine Phenyl N-(2-methoxynaphth-3-yl)carbamate and l-(3,5-dimethoxyphenyl)piperazine were reacted by the same way with lδ the example 86 to obtain the titled compound. yield : 74.δ% m.p. : 191 - 193 ° C Example 88) l-[(2-Methoxynaphth-3-yl)aminocarbonyl]-4-(3,δ-difluorophenyl) 20 piperazine Phenyl N-(2-methoxynaphth-3-yl)carbamate and l-(3,δ-difluorophenyl)piperazine were reacted by the same way with the example 86 to obtain the titled compound. yield : 78.δ% 2δ m.p. : 160- 161 °C Example 89) 1- [(2-Methoxynaphth-3-yl)aminocarbonyl]-4- (3,δ-dichlorophenyl) piperazine Phenyl N-(2-methoxynaphth-3-yl)carbamate and 30 l-(3,5-dichlorophenyl)piperazine were reacted by the same way with the example 86 to obtain the titled compound. yield : 76.7% m.p. : 182- 184 ° C Example 90) l-[(2-Methoxynaphth-3-yl)-N-methylaminocarbonyl]-4- (3,δ-dimethylphenyl)piperazine δ To l-[(2-methoxynaphth-3-yl)aminocarbonyl]-4-(3,δ-dimethylphenyl)- piperazine(210mg, O.δ4mmol) dissolved in dimethylformamide(lδml), 60% sodium hydride(21.δmg, O.δ4mmol) was added, stirred at room temperature for lδ minutes, and thereto methyl iodide (76.6mg, O.δ4mmol) was added. The resulting mixture was stirred at room 10 temperature for 6 hours, concentrated under the reduced pressure to remove the solvent and purified by column chromatography to obtain the titled compound. yield : 86.4% m.p. : 134- 136 ° C lδ Example 91) l-[(2-Methoxynaphth-3-yl)-N-methylaminocarbonyl]-4- (3,δ-difluorophenyl)piperazine l-[(2-Methoxynaphth-3-yl)aminocarbonyl]-4-(3,δ-difluorophenyl)- piperazine was reacted by the same way with the example 90 to obtain the titled compound. 20 yield : 8δ.0% m.p. : 115- 1171 Example 92) l-[(2-Methoxynaphth-3-yl)-N-methylaminocarbonyl]-4- (3,δ-dichlorophenyl)piperazine l-[(2-Methoxynaphth-3-yl)aminocarbonyl]-4-(3,δ-dichlorophenyl)- 2δ piperazine was reacted by the same way with the example 90 to obtain the titled compound. yield : 89.8% m.p. : 16δ~ 167 ° C Example 93) l-t(2-Methoxynaphth-3-yl)-N-methylaminocarbonyl]-4- 30 (3,δ-dimethoxyphenyl)piperazine 1- [(2-Methoxynaphth-3-yl)aminocarbonyl]-4- (3,δ-dimethoxyphenyl)- piperazine was reacted by the same way with the example 90 to obtain the titled compound. yield : 92.δ% m.p. : 83~8δ°C δ Example 94) l-[(2-Methoxynaphth-3-yl)-N-ethylaminocarbonyl]-4- (3,δ-dimethylphenyl)piperazine To 1 - [ (2-methoxynaphth-3-yl)aminocarbonyl] -4- (3,δ-dimethylphenyl) piperazine(210mg, O.δ4mmol) dissolved in dimethylformamide(lδml), 60% sodium hydride(21.δmg, O.δ4mmol) was added, stirred at room 10 temperature for lδ minutes, and thereto methyl iodide (84.2mg, 0.54mmol) was added. The mixture was stirred at room temperature for 6 hours, concentrated under the reduced pressure to remove the solvent and purified by column chromatography to obtain the titled compound. yield : 70.2% lδ Example 95) l-[(2-Methoxynaphth-3-yl)-N-ethylaminocarbonyl]-4- (3,δ-dimethoxyphenyl)piperazine l-[(2-Methoxynaphth-3-yl)aminocarbonyl]-4-(3,δ-dimethoxyphenyl)- piperazine was reacted by the same way with the example 94 to obtain the titled compound. 20 yield : 8δ.0% Example 96) N-Hydroxy-N'-(δ,6-dimethyl-2-methoxypyridin-3-yl)- (4-phenylpiperazin- 1 -yDcarboxyimidamide To methyl N-(δ,6-dimethyl-2-methoxypyridin-3-yl)-(4-phenyl- piperazin-l-yl)iminothiorate (O.δOg, 1.35mmol) dissolved in chloroform 25 (30ml), hydroxylamine hydrochlroride (0.25g, 3.60mmol) and triethylamine (0.41g, 4.0δmmol) were added and stirred at room temperature for lδ hours, and then thereto water(30ml) was added to stop reaction. The resulting mixture was extracted with methylene chloride. The organic layer was concentrated under the reduced pressure to remove the 30 solvent and purified by column chromatography to obtain the titled compound. yield : 64.δ% m.p. : 173~ 17δ ° C Example 97) N-Hydroxy-N'-(δ,6-dimethyl-2-methoxypyridin-3-yl)- [4-(4-methylphenyl)piperazin-l-yl]carboxyimidamide δ Methyl N-(5,6-dimethyl-2-methoxypyridin-3-yl)-[4-(4-methylphenyl)- piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 55.2% m.p. : 187- 189 ° C 10 Example 98) N-Hydroxy-N'-(5,6-dimethyl-2-methoxypyridin-3-yl)- [4-(4-n-butylphenyl)piperazin-l-yl]carboxyimidamide Methyl N- (δ,6-dimethyl-2-methoxypyridin-3-yl)- [4- (4-n-butylphenyl) - piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound, lδ yield : 60.1% m.p. : lδ3~ lδδ ° C Example 99) N-Hydroxy-N'-(δ,6-dimethyl-2-methoxypyridin-3-yl)- [4-(3,δ--dimethylphenyl)piperazin-l-yl]carboxyimidamide Methyl 20 N-(δ,6--dimethyl-2-methoxypyridin-3-yl)-[4-(3,δ-dimethylphenyl)- piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 67.δ% m.p. : 12δ~128 ° C 2δ Example 100) N-Hydroxy-N'-(δ,6-dimethyl-2-methoxypyridin-3-yl)-[4-(2-methoxy- phenyl)piperazin-l-yl]carboxyimidamide Methyl N-(δ,6-dimethyl-2-methoxypyridin-3-yl)-[4-(2-methoxyphenyl)- 30 piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 62.0% m.p. : 134- 136 °C Example 101 ) N-Hydroxy-N ' - (δ,6-dimethyl-2-methoxypyridin-3-yl) - [4- (3,δ-dimethoxyphenyl)piperazin- 1 -yl]carboxyimidamide δ Methyl N-(δ,6-dimethyl-2-methoxypyridin-3-yl)-[4-(3,δ-dimethoxy- phenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : δ7.2% m.p. : 188- 190 °C 10 Example 102) N-Hydroxy-N '-(δ,6-dimethyl-2-methoxypyridm-3-yl)- [4-(3,δ-difluorophenyDpiperazin-l-yl]carboxyimidamide Methyl N- (δ,6-dimethyl-2-methoxypyridin-3-yl)- [4- (3,δ-difluoro- phenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound, lδ yield : 60.7% m.p. : 177- 178 °C Example 103) N-Hydroxy-N '- (δ,6-dimethyl-2-methoxypyridin-3-yl)- [4- (3,5-dichlorophenyl)piperazin- 1 -yl]carboxyimidamide Methyl N-(5,6-dimethyl-2-methoxypyridin-3-yl)-[4-(3,δ-dichloro- 20 phenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 6δ.4% m.p. : 18δ~187 ° C Example 104) 2δ N-Hydroxy-N' -(δ,6-dimethyl-2-methoxypyridin-3-yl)-[4-(3-bromo- phenyl)piperazin-l-yl]carboxyimidamide Methyl N- (δ,6-dimethyl-2-methoxypyridin-3-yl)- [4- (3-bromophenyl) - piperazine- l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. 30 yield : 68.1% m.p. : 174- 176 °C Example lOδ) N-Hydroxy-N'-(δ,6-dimethyl-2-methoxypyridin-3-yl)-[4- (3,δ--dinitrophenyl)piperazin-l-yl]carboxyimidamide Methyl N- (5,6-dimethyl-2-methoxypyridin-3-yl) - [4- (3,δ-dinitro- phenyl)piperazin-l-yl]iminothiolate was reacted by the same way with δ the example 96 to obtain the titled compound. yield : 4δ.2% m.p. : 193- 195 °C Example 106) N-Hydroxy-N'-(5,6-dimethyl-2-methoxypyridin-3-yl)-[4- (3,δ-diethylisophthal-l-yl)piperazin-l-yl]carboxyimidamide 0 Methyl N-(δ-methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl)- [4-(3,5-diethylisophthal-l-yl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 64.1% m.p. : 166- 168 °C 5 Example 107) N-Hydroxy-N'-(5,6-dimethyl-2-methoxypyridin-3-yl)-{4-[3,δ-bis- (hydroxymethyl)phenyl]piperazin- 1 -yllcarboxyimidamide To N-hydroxy-N ' - (δ,6-dimethyl-2-methoxypyridin-3-yl)- [(4-(3,δ-diethylisophthal-l-yl)piperazin-l-yl]carboxyimidamide (δOOmg, 0 l.Ommol) dissolved in tetrahydrofuran(20ml), lithium aluminium hydride (δ7mg, l.δmmol) were added slowly, and stirred at 20°C for 1 hours, and then thereto water(O.δml) was added to stop reaction. The resulting mixture was concentrated under the reduced pressure to remove the solvent and extracted with methylene chloride with addition of water. δ The organic layer was dried with magnesium sulfate and purified by column chromatography to obtain the titled compound. yield : 42.1% m.p. : 184- 186 °C Example 108) 0 N-Hydroxy-N ' - (δ-ethyl-2-methoxy-6-methylpyridin-3-yl)- [4-(2-methoxyphenyl)piperazin-l-yl]carboxyimidamide Methyl N- (δ-ethyl-2-methoxy-6-methylpyridin-3-yl)- [4-(2-methoxyphenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 69.4% δ m.p. : 134~ 13δ ° C Example 109) N-Hydroxy-N ' - (δ-ethyl-2-methoxy-6-methylpyridin-3-yl)- [4- (3,δ~di- methoxyphenyl)piperazin-l-yl]carboxyimidamide Methyl 10 N- (δ-ethyl-2-methoxy-6-methylpyridin-3-yl)- [4- (3,5-dimethox- yphenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 68.2% m.p. : 140~ 142 ° C lδ Example 110) N-Hydroxy-N ' - (δ-ethyl-2-methoxy-6-methylpyridin-3-yl)- [4- (2-ethyl- phenyl)piperazin-l-yl]carboxyimidamide Methyl N-(δ-ethyl-2-methoxy-6-methylpyridin-3-yl)-[4-(2-ethylphen-yl)- 20 piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 70.2% m.p. : lδ7~ 160 ° C Example 111) 2δ N-Hydroxy-N'-(δ-ethyl-2-methoxy-6-methylpyridin-3-yl)-(4-phenyl- piperazin- 1 -yDcarboxyimidamide Methyl N-(δ-ethyl-2-methoxy-6-methylpyridin-3-yl)-(4-phenyl- piperazin-l-yl)iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. 30 yield : 72.2% m.p. : 178- 180 ° C Example 112) N-Hydroxy-N' -(δ-ethyl-2-methoxy-6-methylpyridin-3-yl)- [4-(2-methylthiophenyl)piperazin-l-yl]carboxyimidamide Methyl N-(δ-ethyl-2-methoxy-6-methylpyridin-3-yl)-[4-(2-methyl- δ thiophenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 69.3% m.p. : 178- 179 °C Example 113) 10 N-Hydroxy-N' -(δ-ethyl-2-methoxy-6-methylpyridin-3-yl)- [4-(3,δ-dimethylphenyl)piperazin-l-yl]carboxyimidaιnide Methyl N- (δ-ethyl-2-methoxy-6-methylpyridin-3-yl)- [4- (3,δ-dimethyl- phenyl)piperazin-l-yl]iminothiolate was reacted by the same way with lδ the example 96 to obtain the titled compound. yield : 64.7% m.p. : 155~ lδ7°C Example 114) N-Hydroxy-N'-(δ-ethyl-2-methoxy-6-methylpyridin-3-yl)-[4-(3,δ-di- 20 fluorophenyl)piperazin-l-yl]carboxyimidamide Methyl N-(5-ethyl-2-methoxy-6-methylpyridin-3-yl)-[4-(3,δ-difluoro- phenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 51.8% 25 m.p. : lδO~ 152°C Example 115) N-Hydroxy-N ' - (δ-ethyl-2-methoxy-6-methylpyridin-3-yl) - [4- (3,δ-dichlorophenyl)piperazin-l-yl]carboxyimidamide Methyl N- (δ-ethyl-2-methoxy-6-methylpyridin-3-yl) - [4- (3,5-dichloro- 30 phenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 72.2% m.p. : 172- 174 ° C Example 116) N-Hydroxy-N ' - (δ-ethyl-2-methoxy-6-methylpyridin-3-yl)- [4- δ (2-biphenyl)piperazin-l-yl]carboxyimidamide Methyl N-(δ-ethyl-2-methoxy-6-methylpyridin-3-yl)-[4-(2-biphenyl)- piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : δ3.4% 10 m.p. : 195- 197 ° C Example 117) N-Hydroxy-N ' - (δ-ethyl-2-methoxy-6-methylpyridin-3-yl)- [4- (3,δ-dinitrophenyl)piperazin-l-yl]carboxyimidamide Methyl N-(δ-ethyl-2-methoxy-6-methylpyridin-3-yl)-[4-(3,δ-dinitro- lδ phenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 44.3% m.p. : 193- 195 °C Example 118) 20 N-Hydroxy-N ' - (5-methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl) - [4-(3,δ-dimethoxyphenyl)piperazin-l-yl]carboxyimidamide Methyl N- (δ-methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl)- [4-(3,δ-dimethoxyphenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. 25 yield : 61.6% m.p. : 192- 194 ° C Example 119) N-Hydroxy-N' - (5-methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl)- [4-(3,δ-dimethylphenyl)piperazin-l-yl]carboxyimidamide 30 Methyl N-(δ-methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl)- [4-(3,δ-dimethylphenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 63.0% m.p. : 19δ~ 197 ° C Example 120) δ N-Hydroxy-N ' - (5-methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl) - [4-(3,δ-difluorophenyl)piperazin-l-yl]carboxyimidamide Methyl N- (δ-methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl) - [4- (3,δ- difluorophenyl)piperazin-l-yl]iminothiolate was reacted by the same 10 way with the example 96 to obtain the titled compound. yield : δ7.4% m.p. : 170- 172 ° C Example 121) N-Hydroxy-N' - (δ-methoxycarbonyl-2-methoxy-6-methylpyridine-3-yl)- lδ [4-(2-methoxyphenyl)piperazin-l-yl]carboxyimidamide Methyl N- (δ-methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl)- [4-(2-methoxyphenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 65.1% 20 m.p. : 176- 178 ° C Example 122) N-Hydroxy-N ' - (δ-methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl) - (4-phenylpiperazin-l-yl)carboxyimidamide Methyl N- (5-methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl) - 25 (4-phenylpiperazin-l-yl)iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 69.5% m.p. : 194- 196 ° C Example 123) 30 N-Hydroxy-N ' - (5-methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl) - [4-(4-methylphenyl)piperazin-l-yl]carboxyimidamide Methyl N- (5-methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl) - [4-(4-methylphenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 73.2% m.p. : 190- 192 °C Example 124) N-Hydroxy-N ' - (δ-methoxycarbonyl-2-methoxy-6-methylpyridine-3-yl)- [4-(3-chlorophenyl)piperazin-l-yl]carboxyimidamide Methyl N-(δ-methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl)- [4-(3-chlorophenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 60.2% m.p. : 91~93°C Example 125) N-Hydroxy-N ' - (5-hydroxymethyl-2-methoxy-6-methylpyridin-3-yl) - [4-(3,δ-dimethoxyphenyl)piperazin-l-yl]carboxyimidamide To N-hydroxy-N ' - (δ-methoxycarbonyl-2-methoxy-6-methyl- pyridin-3-yl)-[(4-(3,δ-dimethoxyphenyl)piperazin-l-yl]carboxyimidamide (300mg, 0.6δmmol) dissolved in tetrahydrofuran(20ml), lithium aluminium hydride(37mg, 0.98mmol) was added slowly and stirred at 20 °C for 1 hours. Then, water(O.δml) was added thereto to stop reaction. The resulting mixture was concentrated under the reduced pressure to remove the solvent, and extracted with methylene chloride with addition of water. The organic layer was dried with magnesium sulfate, and purified by column chromatography to obtain the titled compound. yield : 4δ.8% m.p. : 18δ~187°C Example 126) N-Hydroxy-N ' - (δ-hydroxymethyl-2-methoxy-6-methylpyr-idine-3-yl) - [4- (3,δ-dimethylphenyl)piperazin- 1 -yl]carboxyimidamide Methyl N- (δ-hydroxymethyl-2-methoxy-6-methylpyridin-3-yl)- [4-(3,δ-dimethylphenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 12δ to obtain the titled compound. yield : 47.3% m.p. : 127- 129 ° C δ Example 127) N-Hydroxy-N'-(δ-hydroxymethyl-2-methoxy-6-methylpyridin-3-yl)- [4- (3,δ-difluorophenyl)piperazin- 1 -yl] carboxy imidamide Methyl N- (δ-hydroxymethyl-2-methoxy-6-methylpyridin-3-yl)- [4-(3,δ-difluorophenyl)piperazin-l-yl]iminothiolate was reacted by the 10 same way with the example 12δ to obtain the titled compound. yield : 42.3% m.p. : 179- 181 °C Example 128) N-Hydroxy-N' -(δ-hydroxymethyl-2-methoxy-6-methylpyridin-3-yl)- lδ [4- (2-methoxyphenyl)piperazin-l-yl]carboxyimid-amide Methyl N- (δ-hydroxymethyl-2-methoxy-6-methylpyridin-3-yl)- [4-(2-methoxyphenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 12δ to obtain the titled compound. yield : δ7.5% 20 m.p. : 129- 131 °C Example 129) N-Hydroxy-N' -(5-hydroxymethyl-2-methoxy-6-methylpyr-idine-3-yl)- (4-phenylpiperazin- 1 -yDcarboxyimidamide Methyl N- (δ-hydroxymethyl-2-methoxy-6-methylpyridin-3-yl)- 2δ (4-phenylpiperazin-l-yl)iminothiolate was reacted by the same way with the example 12δ to obtain the titled compound. yield : 61.6% m.p. : 167- 169 °C Example 130) 30 N-Hydroxy-N ' - (δ-hydroxymethyl-2-methoxy-6-methylpyridin-3-yl)- [4- (4-methylphenyl)piperazin- 1 -yl]carboxyimidamide Methyl N-(δ-hydroxymethyl-2-methoxy-6-methylpyridin-3-yl)-[4-(4-methylphe nyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 12δ to obtain the titled compound. yield : 66.7% m.p. : lδ7~lδ9°C Example 131) N-Hydroxy-N'-(δ-hydroxymethyl-2-methoxy-6-methylpyridin-3-yl)- [4-(3-chlorophenyl)piperazin-l-yl]carboxyimidamide Methyl N-(δ-hydroxymethyl-2-methoxy-6-methylpyridin-3-yl)- [4-(3-chlorophenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 12δ to obtain the titled compound. yield : 56.2% m.p. : 171- 173 ° C Example 132) N-Hydroxy-N ' - (5-acetyl-2-methoxy-6-methylpyridin-3-yl) - [4-(3,5-dimethylphenyl)piperazin-l-yl]carboxyimidamide Methyl N- (δ-acetyl-2-methoxy-6-methylpyridin-3-yl)- [4- (3,δ-dimethyl- phenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 35.1% m.p. : 174~176°C Example 133) N-Hydroxy-N '-(5-acetyl-2-methoxy-6-methylpyridin-3-yl) -[4- (3,δ-di- methoxyphenyDpiperazin- 1 -yl] carboxyimidamide Methyl N- (δ-acetyl-2-methoxy-6-methylpyridin-3-yl)-[4- (3,5-di- methoxyphenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 32.4% m.p. : 143- 145 °C Example 134) N-Hydroxy-N ' - (5-acetyl-2-methoxy-6-methylpyridin-3-yl) - (4-phenylpiperazin- 1 -yDcarboxyimidamide Methyl N-(5-acetyl-2-methoxy-6-methylpyridin-3-yl)-(4-phenyl- δ piperazin-l-yl)iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 40.δ% m.p. : 169- 170 ° C Example 13δ) 10 N-Hydroxy-N'-(5-acetyl-2-methoxy-6-methylpyridin-3-yl)- [4- (4-methylphenyl)piperazin- 1 -yl]carboxyimidamide Methyl N- (δ-acetyl-2-methoxy-6-methylpyridin-3-yl)- [4- (4-methyl- phenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound, lδ yield : δδ.2% m.p. : 164- 166 °C Example 136) N-Hydroxy-N '- (δ-acetyl-2-methoxy-6-methylpyridin-3-yl) - [4- (3,δ-difluorophenyl)piperazin- 1 -yl]carboxyimidamide 20 Methyl N- (δ-acetyl-2-methoxy-6-methylpyridin-3-yl)-[4- (3,δ-difluoro- phenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 33.2% 2δ m.p. : 184-18δ°C Example 137) N-Hydroxy-N ' - (δ-acetyl-2-methoxy-6-methylpyridin-3 ~ yl) - [4- (2-methylthiophenyl)piperazin- 1 -yl] carboxyimidamide Methyl N- (δ-acetyl-2-methoxy-6-methylpyridin-3-yl)-[4- (2-methyl- 30 thiophenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 39.8% m.p. : 178- 179 ° C Example 138) N-Hydroxy-N '- [δ- (1 -hydroxyethyl) -2-methoxy-6-methylpyridin-3-yl] - δ [4-(3,δ-dimethylphenyDpiperazin-l-yl]carboxyimidamide To N-hydroxy-N'-(δ-acetyl-2-methoxy-6-methylpyridin-3-yl)- [(4- (3,δ-dm ethylphenyl)piperazin-l-yl]carboxyimidarnide (lδOmg, 0.36mmol), ethanol(20ml) and then sodium borohydride(17mg, 0.4δmmol) were added slowly. The resulting mixture was stirred at 20 °C for 4 10 hours, concentrated under the reduced pressure to remove the solvent, and extracted with methylene chloride with addition of water. The organic layer was dried with magnesium sulfate and purified by column chromatography to obtain the titled compound. yield : 7δ.6% lδ m.p. : 94~96°C Example 139) N-Hydroxy-N'-[δ-(l-hydroxyethyl)-2-methoxy-6-methylpyridin-3-yl]- [4-(3,δ--dimethoxyphenyl)piperazin-l-yl]carboxyimidamide Methyl N- [5- ( 1 -hydroxyethyl) -2-methoxy-6-methylpyridin-3-yl] - [4- 20 (3,δ-dimethoxyphenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 138 to obtain the titled compound. yield : 6δ.6% m.p. : 123- 125 °C Example 140) N-Hydroxy-N' -[5-(l-hydroxyethyl)-2-methoxy-6-methyl- 2δ pyridin-3-yl] - (4-phenylpiperazin- 1 -yDcarboxyimidamide Methyl N- [5- ( 1 -hydroxyethyl) -2-methoxy-6-methylpyridin-3-yl] - (4-phenylpiperazin- l-yl)iminothiolate was reacted by the same way with the example 138 to obtain the titled compound. yield : 72.3% 30 m.p. : lδ4~ lδδ°C Example 141) N-Hydroxy-N ' - [5- ( 1-hydroxy ethyl) -2-methoxy-6-methylpyridin-3-yl] - [4- (4-methylphenyl)piperazin- 1 -yl]carboxyimidamide Methyl N- [5- ( 1 -hydroxyethyl) -2-methoxy-6-methylpyridin-3-yl] - [4-(4-methylphenyl)piperazin-l-yl]iminothiolate was reacted by the same 5 way with the example 138 to obtain the titled compound. yield : 62.1% m.p. : 187- 189 °C Example 142) N-Hydroxy-N ' - [5- ( 1 -hydroxyethyl) -2-methoxy-6-methylpyridin-3-yl] - 10 [4-(3,δ-difluorophenyl)piperazin-l-yl]carboxyimidamide Methyl N- [5- ( 1 -hydroxyethyl) -2-methoxy-6-methylpyridin-3-yl] - [4-(3,δ-difluorophenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 138 to obtain the titled compound. yield : 63.8% lδ m.p. : 156~ lδ7 ° C Example 143) N-Hydroxy-N ' - [5- ( 1 -hydroxyethyl) -2-methoxy-6-methylpyridin-3-yl] - [4-(2-methylthiophenyl)piperazin-l-yl]carboxyimidamide Methyl N- [5- ( 1-hydroxyethyl) -2-methoxy-6-methylpyridin-3-yl] - 20 [4-(2-methylthiophenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 138 to obtain the titled compound. yield : 70.2% m.p. : 162- 163 ° C Example 144) 2δ N-Hydroxy-N ' - [5- ( 1 -hydroxyiminoethyl) -2-methoxy-6-methyl- pyridin-3-yl] - [4- (3,δ-dimethylphenyl)piperazin- 1 -yl]carboxyimidamide Methyl N-(δ-acetyl-2-methoxy-6-methylpyridin-3-yl)-[4- (3,δ-dimethylphenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. 30 yield : 23.2% Example 145) N-Hydroxy-N ' - [5- (1 -hydroxyiminoethyl) -2-methoxy-6-methylpyridin-3- yl] - [4- (3,δ-dimethoxyphenyl)piperazin- 1-yl] carboxy imidamide Methyl N-(δ-acetyl-2-methoxy-6-methylpyridin-3-yl)-[4-(3,δ- dimethoxyphenyl)piperazin-l-yl]iminothiolate was reacted by the same δ way with the example 96 to obtain the titled compound. yield : 3δ.6% Example 146) N-Hydroxy-N ' - [5- (1 -hydroxyiminoethyl)-2-methoxy-6-methylpyridin-3- yl] - [4- (3,5-difluorophenyl)piperazin- 1 -yl]carboxyimidamide 10 Methyl N-(δ-acetyl-2-methoxy-6-methylpyridin-3-yl)-[4-(3,δ- difluorophenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 33.3% Example 147) lδ N-Hydroxy-N ' - [5- ( 1 -hydroxyiminoethyl) -2-methoxy-6-methylpyridin-3- yl]-[4-(2-methylthiophenyl)piperazin-l-yl]carboxyimidamide Methyl N-(5-acetyl-2-methoxy-6-methylpyridin-3-yl)-[4-(2-methyl- thiophenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. 20 yield : 30.2% Example 148) N-Hydroxy-N'-[5-(l-hydroxyiminoethyl)-2-methoxy-6-methylpyridin-3- yl] - [4- (3,δ-dinitrophenyl)piperazin-l-yl]carboxyimidamide Methyl N- (5-acetyl-2-methoxy-6-methylpyridin-3-yl)- [4- (3,5- 25 dinitrophenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 29.5% Example 149) N-Hydroxy-N ' - [5- ( 1 -hydroxyiminoethyl)-2-methoxy-6-me-thylpyridin-3 30 -yl] - [4- (4-methylphenyl)piperazin- 1 -yl]carboxyimidamide Methyl N- (δ-acetyl-2-methoxy-6-methylpyridin-3-yl)- [4- (4- methylphenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 2δ.0% Example 150) N-Hydroxy-N'-[δ-(l-aminoethyl)-2-methoxy-6-methylpyridin-3-yl]-[4- (3,δ-dimethylphenyl)piperazin-l-yl]carboxyimidamide Methyl N- [5- ( 1 -aminoethyl) -2-methoxy-6-methylpyridin-3-yl] - [4-(3,δ-dimethylphenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 4δ.6% Example lδl) N-Hydroxy-N ' - [5- ( 1 -aminoethyl) -2-methoxy-6-methylpyridin-3-yl] - [4-(3,δ-dimemoxyphenyl)piperazin-l-yl]carboxyimidamide Methyl N- [5- ( 1 -aminoethyl) -2-methoxy-6-methylpyridin-3-yl] - [4-(3,δ-dimethoxyphenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 42.2% Example lδ2) N-Hydroxy-N ' - [5- (l-aminoethyl)-2-methoxy-6-methylpyridin-3-yl] - [4-(3,δ-difluorophenyl)piperazin-l-yl]carboxyimidamide Methyl N- [5- ( 1 -aminoethyl) -2-methoxy-6-methylpyridin-3-yl] - [4-(3,δ-difluorophenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 53.1% Example 153) N-Hydroxy-N' -[5- (l-aminoethyl)-2-methoxy-6-methylpyridin-3-yl]- [4-(2-methylthiophenyl)piperazin-l-yl]carboxyimidamide Methyl N- [5- ( 1 -aminoethyl) -2-methoxy-6-methylpyridin-3-yl] - [4-(2-methylthiophenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 44.7% Example 154) N-Hydroxy-N' -[δ-d-aminoethyl)-2-methoxy-6-methylpyridin-3-yl]- [4-(3,δ-dinitrophenyl)piperazin-l-yl]carboxyimidamide Methyl δ N- [5- ( 1 -aminoethyl) -2-methoxy-6-methylpyridin-3-yl] - [4- (3,δ- dinitrophenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 52.1% Example 15δ) 10 N-Hydroxy-N'-[δ-(l-aminoethyl)-2-methoxy-6-methylpyridin-3-yl]- [4- (3,δ-chlorophenyl)piperazin- 1 -yl]carboxyimidamide Methyl N- [5- ( 1 -aminoethyl) -2-methoxy-6-methylpyridin-3-yl] - [4- (3,δ-chlorophenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound, lδ yield : 47.6% Example lδ6) N-Hydroxy-N '- (6-ethyl-δ-methoxycarbonyl-2-methoxypyridin-3-yl) - [4- (4-methylphenyl)piperazin- 1 -yl]carboxyimidamide Methyl N- (6-ethyl-δ-methoxycarbonyl-2-methoxypyridin-3-yl)- 20 [4-(4-methylphenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 71.2% m.p. : 176- 178 ° C Example 157) 25 N-Hydroxy-N ' - (6-ethyl-δ-methoxycarbonyl-2-methoxypyridin-3-yl) - [4- (2-ethylphenyDpiperazin-l-yl]carboxyimidamide Methyl N- (6-ethyl-δ-methoxycarbonyl-2-methoxypyridin-3-yl) - [4- (2- ethylphenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. 30 yield : 65.0% m.p. : 182- 184 °C Example 158) N-Hydroxy-N'-(6-ethyl-5-methoxycarbonyl-2-methoxypyridin-3-yl)- [4-(3,δ-dimethylphenyl)piperazin-l-yl]carboxyimidamide Methyl N- (6-ethyl-δ-methoxycarbonyl-2-methoxypyridin-3-yl) - δ [4-(3,δ-dimethylphenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 59.1% m.p. : 152~lδδ°C Example lδ9) 0 N-Hydroxy-N ' - (6-ethyl-δ-methoxycarbonyl-2-methoxypyridin-3-yl) - [4- (3,δ-dimethoxyphenyl)piperazin-l-yl]carboxyimidamide Methyl N-(6-ethyl-5-methoxycarbonyl-2-methoxypyridin-3-yl)-[4-(3,5- dimethoxyphenyl)piperazin-l-yl]iminothiolate was reacted by the same 5 way with the example 96 to obtain the titled compound. yield : 5δ.6% m.p. : 156- 157 °C Example 160) N-Hydroxy-N ' - (6-ethyl-δ-methoxycarbonyl-2-methoxypyridin-3-yl)- [4- 0 (3,δ-dichlorophenyl)piperazin-l-yl]carboxyimidamide Methyl N- (6-ethyl-δ-methoxycarbonyl-2-methoxvpyridin-3-yl) - [4- (3,δ-dichlorophenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : δ4.4% δ m.p. : lδ8~ 160°C Example 161) N-Hydroxy-N ' - (6-ethyl-δ-methoxycarbonyl-2-methoxypyridin-3-yl) - [4- (2-methylthiophenyDpiperazin-l-yl]carboxyimidamide Methyl N- (6-ethyl-δ-methoxycarbonyl-2-methoxypyridin-3-yl) - [4- 0 (2-methylthiophenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 501% m.p. : 168- 170 °C Example 162) N-Hydroxy-N ' - (6-ethyl-δ-methoxycarbonyl-2-methoxypyridin-3-yl)- [4- δ (3,δ-diethylisophthalate-l-yl)piperazin-l-yl]carboxyimidamide Methyl N- (6-ethyl-δ-methoxycarbonyl-2-methoxypyridin-3-yl)- [4- (3,δ-diethylisophthal-l-yl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 57.3% 10 m.p. : 101 - 103 °C Example 163) N-Hydroxy-N ' - (6-ethyl-5-methoxycarbonyl-2-methoxypyridin-3-yl) - [4- (3,δ-difluorophenyl)piperazin-l-yl]carboxyimid-amide Methyl N- (6-ethyl-δ-methoxycarbonyl-2-methoxypyridin-3-yl)- lδ [4-(3,δ-difluorophenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 4δ.0% m.p. : 143- 145 °C Example 164) 20 N-Hydroxy-N'-(6-ethyl-δ-hydroxymethyl-2-methoxypyridin-3-yl)- [4- (4-methylphenyl)piperazin- 1 -yl]carboxyimidamide Methyl N- (6-ethyl-δ-hydroxymethyl-2-methoxypyridin-3-yl) - [4- (4-methylphenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 12δ to obtain the titled compound. 2δ yield : 66.6% m.p. : 170- 172 ° C Example 16δ) N-Hydroxy-N'-(6-ethyl-δ-hydroxymethyl-2-methoxypyridin-3-yl)- [4- (2-ethylphenyl)piperazin- 1 -yl]carboxyimidamide 30 Methyl N-(δ-ethyl-2-methoxy-6-methylpyridin-3-yl)-[4-(2-ethyl- phenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 125 to obtain the titled compound. yield : 60.4% m.p. : 185- 187 °C Example 166) 5 N-Hydroxy-N'-(6-ethyl-δ-hydroxymethyl-2-methoxypyridin-3-yl)- [4-(3,δ-dimethylphenyl)piperazin-l-yl]carboxyimidamide Methyl N- (6-ethyl-δ-hydroxymethyl-2-methoxypyridin-3-yl) - [4-(3,δ-dimethylphenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 12δ to obtain the titled compound. 10 yield : 65.1% m.p. : 7δ~77 ° C Example 167) N-Hydroxy-N ' - (6-ethyl-δ-hydroxymethyl-2-methoxypyridin-3-yl) - [4- (3,δ-dimethoxyphenyl)piperazin- 1-yl] carboxy imidamide lδ Methyl N- (6-ethyl-δ-hydroxymethyl-2-methoxypyridin-3-yl) - [4- (3,5- dimethoxyphenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 125 to obtain the titled compound. yield : 61.2% m.p. : 67~69 ° C 20 Example 168) N-Hydroxy-N ' - (6-ethyl-5-hydroxymethyl-2-methoxypyridin-3-yl)- [4- (3, δ-dichlorophenyl)piperazin- 1 -yl]carboxyimidamide Methyl N-(6-ethyl-5-hydroxymethyl-2-methoxypyridin-3-yl)-[4-(3,5- dichlorophenyl)piperazin-l-yl]iminothiolate was reacted by the same way 2δ with the example 12δ to obtain the titled compound. yield : 701% m.p. : 7δ-77 ° C Example 169) N-Hydroxy-N' -(6-ethyl-δ-hydroxymethyl-2-methoxypyridin-3-yl)- 30 [4-(2-methylthiophenyl)piperazin-l-yl]carboxyimidamide Methyl N- (6-ethyl-δ-hydroxymethyl-2-methoxypyridin-3-yl) - [4- (2- methylthiophenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 12δ to obtain the titled compound. yield : 67.2% m.p. : 163~ 16δ°C 5 Example 170) N-Hydroxy-N '- (6-ethyl-5-hydroxymethyl-2-methoxypyridin-3-yl) - {4- [3,δ-bis (hydroxymethyl)phenyl]piperazin- 1 -yl }carboxyimidamide Methyl N- (6-ethyl-δ-hydroxymethyl-2-methoxypyridin-3-yl) - {4- [3,δ- bis(hydroxymethyl)phenyl]piperazin-l-yl}iminothiolate was reacted by the 10 same way with the example 12δ to obtain the titled compound yield : δ9.4% Example 171) N-Hydroxy-N'-(6-ethyl-δ-hydroxymethyl-2-methoxypyridin-3-yl)-[4- (3,δ-difluorophenyl)piperazin-l-yl]carboxyimidamide lδ Methyl N- (6-ethyl-5-hydroxymethyl-2-methoxypyridin-3-yl) - [4- (3,5- difluorophenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 125 to obtain the titled compound. yield : 48.7% m.p. : 68~70 ° C 20 Example 172) N-Hydroxy-N ' - (2-methoxyquinolin-3-yl) - [4- (3,5-dimethoxyphenyl)- piperazin- 1 -yl]carboxyimidamide Methyl N-(2-methoxyquinolin-3-yl)-[4-(3,δ-dimethoxyphenyl)- piperazin-l-yl]iminothiolate was reacted by the same way with the 2δ example 96 to obtain the titled compound. yield : 41.0% iap. : 21δ~217 ° C Example 173) N-Hydroxy-N ' - (2-methoxyquinolin-3-yl) - [4- (3,δ-dimethylphenyl) - 30 piperazin-l-yl]carboxyimidamide Methyl N-(2-methoxyquinolin-3-yl)-[4-(3,δ-dimethylphenyl)- piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 44.2% m.p. : 182- 184 ° C Example 174) N-Hydroxy-N ' - (2-methoxyquinolin ~ 3-yl) - [4- (3,5-difluoro-phenyl) - piperazin- 1 -yl] carboxyimidamide Methyl N-(2-methoxyquinolin-3-yl)-[4-(3,δ-difluorophenyl)- piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 38.1% m.p. : 163- 165 ° C Example 175) N-Hydroxy-N ' - (2-methoxyquinolin-3-yl) - [4- (2-methoxyphenyl) - piperazin-l-yl]carboxyimidamide Methyl N-(2-methoxyquinolin-3-yl)-[4-(2-methoxyphenyl)- piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 43.2% m.p. : 210- 212 °C Example 176) N-Hydroxy-N ' - (2-methoxyquinolin-3-yl) - [4- (3-chlorophenyl) - piperazin- 1 -yl] carboxyimidamide Methyl N-(2-methoxyquinolin-3-yl)-[4-(3-chlorophenyl)piperazin-l-yl]- iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 45.2% - m.p. : 162- 164 °C Example 177) N-Hydroxy-N '- (4,δ-dimethyl-2-methoxyphenyl- 1 -yl) - (4-phenyl- piperazin- 1 -yDcarboxyirnidamide Methyl N- (4,δ-dimethyl-2-methoxyphenyl- 1 -yl) - (4-phenylpiperazin- 1 - yDiminothiolate was reacted by the same way with the example 96 to obtain the titled compound, δ yield : 62.7% m.p. : 160- 162 ° C Example 178) N-Hydroxy-N ' - (4,δ-dimethyl-2-methoxyphenyl- 1 -yl) - [4- (4-methyl- phenyl)piperazin-l-yl]carboxyimidamide 10 Methyl N- (4,δ-dimethyl-2-methoxyphenyl- 1 -yl) - [4- (4-methylphenyl) - piperazin- 1 -yDiminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 601% m.p. : 181 - 183 °C lδ Example 179) N-Hydroxy-N'-(4,δ-dimethyl-2-methoxyphenyl-l-yl)-[4-(2-ethyl- phenyl)piperazin-l-yl]carboxyimidamide Methyl N- (4,δ-dimethyl-2-methoxyphenyl- 1 -yl) - [4- (2-ethylphenyl) - piperazin- 1 -yDiminothiolate was reacted by the same way with the 20 example 96 to obtain the titled compound. yield : 6δ.4% m.p. : 194- 196 °C Example 180) N-Hydroxy-N'-(4,δ-dimethyl-2-methoxyphenyl-l-yl)-[4- (3,δ-dimethylphenyl)piperazin- 1 -yDcarboxyirnidamide 2δ Methyl N- (4,δ-dimethyl-2-methoxyphenyl- 1 -yl) - [4- (3,δ-dimethylphenyl) - piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 64.1% 30 m.p. : 184- 186 ° C Example 181) N-Hydroxy-N'-(4,δ-dimethyl-2-methoxyphenyl-l-yl)-[4- (3,δ-dimethoxyphenyl)piperazin-l-yl]carboxyimidamide Methyl N-(4,δ-dimethyl-2-methoxyphenyl-l-yl)-[4-(3,δ-dimethoxy- phenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound, δ yield : 6δ.δ% m.p. : 189- 191 ° C Example 182) N-Hydroxy-N' -(4,δ-dimethyl-2-methoxyphenyl-l-yl)-[4- (3,δ-difluorophenyDpiperazin-l-yl]carboxyimidamide Methyl N- (4,δ-dimethyl-2-methoxyphenyl- 1 -yl) - [4- (3.5-difluoro- 10 phenyl)-piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 60.0% m.p. : 179- 181 ° C Example 183) lδ N-Hydroxy-N' -(4,δ-αlimethyl-2-methoxyphenyl-l-yl)-[4-(3-chloro- phenyl)piperazin-l-yDcarboxyimidamide Methyl N- (4,5-dimethyl-2-methoxyphenyl- 1 -yl) - [4- (3-chlorophenyl) - piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. 20 yield : 58.7% m.p. : 174- 176 ° C Example 184) N-Hydroxy-N ' - (4,δ-dimethyl-2-methoxyphenyl-l -yl)- [4- (3-bromo- phenyl)piperazin-l-yl]carboxyimidamide 2δ Methyl N- (4,δ-dimethyl-2-methoxyphenyl- 1 -yl) - [4- (3-bromophenyl)- piperazin-l-yl]iminothiolate was reacted by the same way with the example 96 to obtain the titled compound. yield : 61.2% m.p. : 178- 180 °C 30 Example 185) N-Hydroxy-N '- (4,5-dimethyl-2-methoxyphenyl- 1 -yl) - [4- (2-methyl- thiophenyDpiperazin- 1 -yDcarboxyirnidamide Methyl N-(4,5-dimethyl-2-methoxyphenyl-l-yl)-[4-(2-methylthio- phenyl)piperazin-l-yl]iminothiolate was reacted by the same way with the ex-ample 96 to obtain the titled compound. 5 yield : 60.δ% m.p. : 194- 196 °C Example 186) N-Methoxy-N'-(5,6-dimethyl-2-methoxypyridin-3-yl)-(4- phenylpiperazin- 1 -yDcarboxyirnidamide To N-hydroxy-N ' - (δ,6-dimethyl-2-methoxypyridin-3-yl) - (4-phenyl- 10 piperazin- 1 -yDcarboxyirnidamide (O.δg, 1.41mmol) dissolved in dimethylformamide (lδml), sodium hydride(60%, δ7.8mg, 1.4δmmol) and methyl iodide (0.20g, 1.41mmol) were added and stirred for 4 hours and then water(20ml) was added thereto to stop reaction. The resulting mixture was extracted with ethylether. The organic layer was lδ concentrated under the reduced pressure to remove the solvent and purified by column chromatography to obtain the titled compound. yield : 89.1% Example 187) N-Methoxy-N ' - (δ,6-dimethyl-2-methoxypyridin-3-yl) - [4- (4-methyl- 20 phenyl)piperazin-l-yl]carboxyimidamide N-Hydroxy-N ' - (δ,6-dimethyl-2-methoxypyridin-3-yl)-[4- (4-methyl- phenyDpiperazin-1 -yDcarboxyirnidamide was reacted by the same way with the example 186 to obtain the titled compound. yield : 92.2% 2δ Example 188) N-Methoxy-N'-(δ,6-dimethyl-2-methoxypyriώn-3-yl)-[4-(3,δ-dimethyl- phenyl)piperazin-l-yl]carboxyimidamide N-Hydroxy-N'-(δ,6-dimethyl-2-methoxypyridin-3-yl)-[4-(3,δ- dimethylphenyl)piperazin-l-yl]carboxyimidamide was reacted by the 30 same way with the example 186 to obtain the titled compound. yield : 90.0% Example 189) N-Methoxy-N ' - (δ,6-dimethyl-2-methoxypyridin-3-yl) - [4- (3,5-di- methoxyphenyl)piperazin-l-yl]carboxyirnidamide N-Hydroxy-N '- (δ,6-dimethyl-2-methoxypyridin-3-yl)-[4- (3,δ-di- δ methoxyphenyl)piperazin-l-yl]carboxyimidamide was reacted by the same way with the example 186 to obtain the titled compound. yield : 92.2% Example 190) N-Methoxy-N ' - (δ,6-dimethyl-2-methoxypyridin-3-yl)- [4- (3-5-difluoro- 10 phenyDpiperazin- 1 -yDcarboxyirnidamide N-Hydroxy-N' -(δ,6-dimethyl-2-methoxypyridin-3-yl)-[4-(3,δ-difluoro- phenyl)piperazin-l-yl]carboxyimidamide was reacted by the same way with the example 186 to obtain the titled compound. yield : 8δ.2% lδ Example 191) N-Methoxy-N'-(δ,6-dimethyl-2-methoxypyridin-3-yl)-[4-(2-methyl- thiophenyDpiperazin- 1 -yDcarboxyirnidamide N-Hydroxy-N'-(δ,6-dimethyl-2-methoxypyridin-3-yl)-[4-(2-methyl- thiophenyl)piperazin-l -yDcarboxyirnidamide was reacted by the same 20 way with the example 186 to obtain the titled compound. yield : 89.2% Example 192) N-Methoxy-N' - (δ,6-dimethyl-2-methoxypyridin-3-yl)-[4- (3,5-dinitro- phenyDpiperazin- 1 -yl] carboxyimidamide 25 N-Hydroxy-N ' - (5,6-dimethyl-2-methoxypyridin-3-yl)- [4- (3,5-dinitro- phenyl)piperazin-l-yl]carboxyimidamide was reacted by the same way with the example 186 to obtain the titled compound. yield : 79.5% Example 193) 30 N-Methoxy-N ' - (δ-ethyl-6-methyl-2-methoxypyridin-3-yl)- [4- (3,5-di- chlorophenyDpiperazin- 1 -yDcarboxyirnidamide N-Hydroxy-N ' - (δ-ethyl-6-methyl-2-methoxypyridin-3-yl)- [4- (3,δ- dichlorophenyl)piperazin-l -yDcarboxyirnidamide was reacted by the same way with the example 186 to obtain the titled compound. yield : 84.2% δ m.p. : 163~ 16δ ° C Example 194) N-Methoxy-N' - (6-ethyl-δ-methoxycarbonyl-2-methoxypyridin-3-yl)- [4-(3,δ-difluorophenyl)piperazin-l-yl]carboxyimid-amide N-Hydroxy-N'-(6-ethyl-δ-methoxycarbonyl-2-methoxypyridin-3-yl)- 0 [4-(3,δ-difluorophenyl)piperazin-l-yl]carboxyimidamide was reacted by the same way with the example 186 to obtain the titled compound. yield : 91.3% Example 19δ) N-Methoxy-N'-(6-ethyl-5-methoxycarbonyl-2-methoxypyridin-3-yl)- 5 [4-(3,5-diethylisophthal-l-yl)piperazin-l-yl]carboxyimidamide N-Hydroxy-N ' - (6-ethyl-δ-methoxycarbonyl-2-methoxypyridin-3-yl) - [4-(3,δ-diethylisophthal-l-yl)piperazin-l-yDcarboxyimidamide was reacted by the same way with the example 186 to obtain the titled compound. 0 yield : 94.0% Example 196) N-Methoxy-N' - (6-ethyl-5-hydroxymethyl-2-methoxypyridin-3-yl)-{4- [3,δ-bis (hydroxymethyl)phenyl- 1 -yDpiperazin- 1 -yDcarboxyirnidamide N-methoxy-N'-(6-ethyl-δ-methoxycarbonyl-2-methoxypyridin-3-yl)- δ [4-(3,δ-diethylisophthal-l-yDpiperazin-l-yl]carboxyimidamide was reacted by the same way with the example 186 to obtain the titled compound. yield : 68.0% Example 197) 0 N-Methoxy-N'-(4,δ-dimethyl-2-methoxyphenyl-l-yl)-[4-(4-methyl- phenyl)piperazin-l-yl]carboxyimidamide N-Hydroxy-N ' - (4,5-dimethyl-2-methoxyphenyl- 1 -yl) - [4- (4-methyl- phenyl)piperazin-l-yl]carboxyimidamide was reacted by the same way with the example 186 to obtain the titled compound. yield : 86.7% δ Example 198) N-Methoxy-N' -(4,δ-dimethyl-2-methoxyphenyl-l-yl)- [4- (3,δ-dimethylphenyl)piperazin- 1 -yl] carboxyimidamide N-Hydroxy-N ' - (4,δ-dimethyl-2-methoxyphenyl- 1 -yl) - [4- (3,5-di- methylphenyl)piperazin-l-yDcarboxyirnidamide was reacted by the same way with the example 186 to obtain the titled compound. 10 yield : 87.0% Example 199) Methyl N- (δ,6-dimethyl-2-methoxypyridin-3-yl) - (4-phenylpiperazin- 1 -yl) - iminothiolate To l-[(δ,6-dimethyl-2-methoxypyridin-3-yl)aminocarbonyl]-4-phenyl- lδ piperazine (O.δg, 1.40mmol) dissolved in dimethylformamide (15ml), sodium hydride (60%, 561mg, 1.40mmol) and methyl iodide (0.20g, 1.41mmol) were added. The resulting mixture was stirred for 2 hours and then water(20ml) was added thereto to stop reaction. The resulting mixture was purified by column chromatography to obtain the titled 20 compound. yield : 92.4% Example 200) Methyl N-(5,6-dimethyl-2-methoxypyridin-3-yl)-[4-(4-et-hylphenyl)- piperazin- 1 -yDiminothiolate 2δ l-[(δ,6-Dimethyl-2-methoxypyridin-3-yl)aminothiocarbonyl]-4-(4- methylphenyDpiperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 9δ.2% Example 201) Methyl N-(δ,6-dimethyl-2-methoxypyridin-3-yl)-[4-(4-n- 30 butylphenyl)piperazin-l-yl]iminothiolate 1 - [ (δ,6-Dimethyl-2-methoxypyridin-3-yl)aminothiocarbonyD -4- (4-n- butylphenyDpiperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 93.4% Example 202) Methyl δ N- (δ,6-dimethyl-2-methoxypyridin-3-yl)- [4- (3,δ-dimethylphenyl) - piperazin- 1 -yl] iminothiolate 1- [(δ,6-Dimethyl-2-methoxypyridin-3-yl)aminothiocarbonyl] -4- (3,5-di- methylphenyDpiperazine was reacted by the same way with the example 199 to obtain the titled compound. 10 yield : 97.2% Example 203) Methyl N-(δ,6-dimethyl-2-methoxypyridin-3-yl)-[4-(2-methoxyphenyl)- piperazin- 1 -yl] iminothiolate l-[(δ,6-Dimethyl-2-methoxypyridin-3-yl)aminothiocarbonyl]-4-(2- lδ methoxyphenyDpiperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 97.4% Example 204) Methyl N-(δ.6-dimethyl-2-methoxypyridin-3-yl)-[4-(3,δ-dimethoxyphenyl)- 20 piperazin- 1 -yDiminothiolate l-[(δ,6-Dimethyl-2-methoxypyridin-3-yl)arninothiocarbonyl]-4-(3,δ- dimethoxyphenyDpiperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 9δ.2% 2δ Example 20δ) Methyl N- (δ,6-dimethyl-2-methoxypyridin-3-yl) - [4- (3,δ-di-fluorophenyl) - piperazin- 1 -yDiminothiolate 1 - [(δ,6-Dimethyl-2-methoxypyridin-3-yl) aminothiocarbonyl] -4- (3,5- difluorophenyDpiperazine was reacted by the same way with the 30 example 199 to obtain the titled compound. yield : 90.1% Example 206) Methyl N-(δ,6-dimethyl-2-methoxypyridin-3-yl)-[4-(3,δ-di-chlorophenyl)- piperazin- 1 -yDiminothiolate 1 - [(5,6-Dimethyl-2-methoxypyridin-3-yl)aminothiocarbonyl] -4- (3,5-di- δ chlorophenyDpiperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 92.δ% Example 207) Methyl N- (δ,6-dimethyl-2-methoxypyridin-3-yl) - [4- (3-bromophenyl) - 10 piperazin-l-yl]iminothiolate 1 - [ (δ,6-Dimethyl-2-methoxypyridin-3-yl)aminothiocarbonyl] -4- (3- bromophenyDpiperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 89.δ% lδ Example 208) Methyl N-(δ,6-dimethyl-2-methoxypyridin-3-yl)-[4-(3,δ-di-nitrophenyl)- piperazin-l-yl]iminothiolate l-[(δ,6-Dimethyl-2-methoxypyridin-3-yl)aminothiocarbonyl]-4-(3,δ- dinitrophenyDpiperazine was reacted by the same way with the example 20 199 to obtain the titled compound. yield : 92.9% Example 209) Methyl N- (δ,6-dimethyl-2-methoxypyridin-3-yl)- [4- (3,5-di-ethylisophthal- 1 -yl) - piperazin- 1 -yDiminothiolate 25 1- [(5,6-Dimethyl-2-methoxypyridin-3-yl)aminothiocarbonyD-4- (3,5- diethylisophthal-l-yl)piperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 92.9% Example 210) Methyl N-(5-ethyl-2-methoxy-6-methylpyridin-3-yl)-(4- 30 phenyl)piperazin-l-yl]iminothiolate 1 - [(δ-Ethyl-2-methoxy-6-methylpyridin-3-yl)aminothiocarbonyl] -4- phenylpiperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 92.2% Example 211) Methyl N-(δ-ethyl-2-methoxy-6-methylpyridin-3-yl)-[4- δ (2-methoxyphenyl)piperazin- 1 -yDiminothiolate 1 - [(δ-Ethyl-2-methoxy-6-methylpyridin-3-yl)aminothiocarbonyD -4- (2-methoxyphenyl)piperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 87.2% 10 Example 212) Methyl N-(δ-ethyl-2-methoxy-6-methylpyridin-3-yl)-[4-(3,δ-dimethoxyphenyl)- piperazin- 1 -yDiminothiolate l-[(δ-Ethyl-2-methoxy-6-methylpyridin-3-yl)aminothiocarbonyl]-4- (3,δ-dimethoxyphenyl)piperazine was reacted by the same way with the lδ example 199 to obtain the titled compound. yield : 92.4% Example 213) Methyl N-(δ-ethyl-2-methoxy-6-methylpyridin-3-yl)-[4- (2-ethylphenyl)piperazin- 1 -yDiminothiolate 1- [(5-Ethyl-2-methoxy-6-methylpyridin-3-yl)aminothiocarbonyD -4- 20 (2-ethylphenyl)piperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 93.6% Example 214) Methyl N-(5-ethyl-2-methoxy-6-methylpyridin-3-yl)- [4-(3,δ-dimethylphenyl)piperazin-l-yl]iminothiolate 2δ l-[(5-Ethyl-2-methoxy-6-methylpyridin-3-yl)aminothiocarbonyl]-4- (3,5-dimethylphenyl)piperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 96.2% Example 215) Methyl 30 N- (5-ethyl-2-methoxy-6-methylpyridin-3-yl)- [4- (3,5-difluorophenyl)- piperazin-l-yl]iminothiolate l-[(δ-Ethyl-2-methoxy-6-methylpyridin-3-yl)aminothiocarbonyl]-4- (3,δ-difluorophenyl)piperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 92.δ% δ Example 216) Methyl N-(δ-ethyl-2-methoxy-6-methylpyridin-3-yl)-[4-(3,δ-dichlorophenyl)- piperazin- 1 -yDiminothiolate l-[(5-Ethyl-2-methoxy-6-methylpyridin-3-yl)aminothiocarbonyl]-4- (3,δ-dichlorophenyl)piperazine was reacted by the same way with the 10 example 199 to obtain the titled compound. yield : 93.2% Example 217) Methyl N-(5-ethyl-2-methoxy-6-methylpyridin-3-yl)-[4- (2-phenylphenyl)piperazin-l-yl]iminothiolate l-[(δ-Ethyl-2-methoxy-6-methylpyridin-3-yl)aminothiocarbonyl]-4- lδ (2-phenylphenyl)piperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 91.4% Example 218) Methyl N-(δ-ethyl-2-methoxy-6-methylpyridin-3-yl)-[4-(3,δ-dinitrophenyl)- 20 piperazin-l-yl]iminothiolate l-[(δ-Ethyl-2-methoxy-6-methylpyridin-3-yl)aminothiocarbonyl]-4- (3,5-dinitrophenyl)piperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 94.2% 25 Example 219) Methyl N-(δ-ethyl-2-methoxy-6-methylpyridin-3-yl)- [4- (2-methylthiophenyl)piperazin- 1 -yDiminothiolate 1- [(δ-Ethyl-2-methoxy-6-methylpyridin-3-yl)aminothiocarbonyD -4- (2-methylthiophenyl)piperazine was reacted by the same way with the example 199 to obtain the titled compound. 30 yield : 90.δ% Example 220) Methyl N-(δ-methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl)-[4-(3,δ- dimethoxyphenyDpiperazin- 1 -yDiminothiolate l-[(δ-Methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl)amino- thiocarbonyl]-4-(3,δ-dimethoxyphenyl)piperazine was reacted by the δ same way with the example 199 to obtain the titled compound. yield : 93.2% Example 221) Methyl N- (δ-methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl)- [4- (3,δ- dimethylphenyDpiperazin- 1 -yDiminothiolate 10 l-[(δ-Methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl)amino- thiocarbonyl]-4-(3,δ-dimethylphenyl)piperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 92.9% Example 222) Methyl lδ N- (δ-methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl)- [4- (3,δ- difluorophenyl)piperazin-l-yl]iminothiolate l-[(δ-Methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl)aminothio- carbonyl]-4-(3,δ-difluorophenyl)piperazine was reacted by the same way with the example 199 to obtain the titled compound. 20 yield : 88.δ% Example 223) Methyl N- (δ-methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl)- [4- (2- methoxyphenyDpiperazin- 1 -yDiminothiolate l-[(δ-Methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl)aminothio- 2δ carbonyl]-4-(2-methoxyphenyl)piperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 90.2% Example 224) Methyl N- (δ-methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl) - (4-phenyl- 30 piperazin- 1 -yDiminothiolate l-[(δ-Methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl)aminothio- carbonyl] -4-phenylpiperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 93.δ% Example 22δ) Methyl δ N-(δ-methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl)-[4-(4-methyl- phenyDpiperazin- 1 -yDiminothiolate l-[(δ-Methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl)aminothi- ocarbonyl]-4-(4-methylphenyl)piperazine was reacted by the same way with the example 199 to obtain the titled compound. 10 yield : 97.δ% Example 226) Methyl N-(δ-methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl)-[4-(2-chloro- phenyl)piperazin-l-yl]iminothiolate l-[(δ-Methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl)aminothio- lδ carbonyl]-4-(2-chlorophenyl)piperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 9δ.δ% Example 227) Methyl N-(2-methoxy-δ-methylcarbonyl-6-methyl- pyridin- 3-yl) - [4- (3,δ-dimethylphenyl)piperazin- 1 -yDiminothiolate 20 1- [(δ-Methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl)aminothio- carbonyl]-4-(3,δ-dimethylphenyl)piperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 96.2% Example 228) Methyl N-(2-methoxy-δ-methylcarbonyl-6-methylpyridin- 25 3-yl)-[4-(3,5-dm ethoxyphenyl)piperazin-l-yl]iminothiolate l-[(5-Methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl)aminothio- carbonyl]-4-(3,δ-dimethoxyphenyl)piperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 9δ.4% 30 Example 229) Methyl N-(2-methoxy-δ-methylcarbonyl-6-methylpyridin- 3-yl) - (4-phenylpiperazin- 1 -yDiminothiolate l-[(δ-Methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl)aminothio- carbonyl]-4-phenylpiperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 90.1% δ Example 230) Methyl N-(2-methoxy-δ-methylcarbonyl-6-methylpyridin- 3-yl)-[4-(4-methylphenyl)piperazin-l-yl]iminothiolate l-[(δ-Methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl)aminothio- carbonyl]-4-(4-methylphenyl)piperazine was reacted by the same way with the example 199 to obtain the titled compound. 10 yield : 92.2% Example 231) Methyl N-(2-methoxy-δ-methylcarbonyl-6-methylpyridin- 3-yl) - [4- (3,δ-difluorophenyl)piperazin- 1 -yDiminothiolate l-[(5-Methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl)aminothio- carbonyl]-4-(3,δ-difluorophenyl)piperazine was reacted by the same way lδ with the example 199 to obtain the titled compound. yield : 93.1% Example 232) Methyl N-(2-methoxy-δ-methylcarbonyl-6-methylpyridin- 3-yl) - [4- (2-methylthiophenyl)piperazin- 1 -yDiminothiolate l-[(δ-Methoxycarbonyl-2-methoxy-6-methylpyridin-3-yl)aminothio- 20 carbonyl] -4- (2-methylthiophenyl)piperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 90.0% Example 233) Methyl N-(6-ethyl-δ-methoxycarbonyl-2-methoxypyridin- 3-yl) - [4- (4-methylphenyl)piperazin- 1 -yDiminothiolate 2δ 1- [(6-Ethyl-δ-methoxycarbonyl-2-methoxypyridin-3-yl)aminothio- carbonyl]-4-(4-methylphenyl)piperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 91.1% Example 234) Methyl N-(6-ethyl-δ-methoxycarbonyl-2-methoxypyridin- 30 3-yl)-[4- (2-ethylphenyl)piperazin-l-yl]iminothiolate 1 - [(6-Ethyl-5-methoxycarbonyl-2-methoxypyridin-3-yl)aminothio- carbonyl] -4- (2-ethylphenyl)piperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 90.4% Example 23δ) Methyl N-(6-ethyl-δ-methoxycarbonyl-2-methoxypyridin- δ 3-yl) - [4- (3,δ-dimethylphenyl)piperazin- 1 -yDiminothiolate l-[(6-Ethyl-δ-methoxycarbonyl-2-methoxypyridin-3-yl)aminothio- carbonyl]-4-(3,δ-dimethylphenyl)piperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 9δ.δ% 10 Example 236) Methyl N-(6-ethyl-δ-methoxycarbonyl-2-methoxypyridin- 3-yl) - [4- (3,δ-dimethoxyphenyl)piperazin- 1 -yDiminothiolate l-[(6-Ethyl-δ-methoxycarbonyl-2-methoxypyridin-3-yl)aminothio- carbonyl]-4-(3,δ-dimethoxyphenyl)piperazine was reacted by the same way with the example 199 to obtain the titled compound, lδ yield : 9δ.4% Example 237) Methyl N-(6-ethyl-δ-methoxycarbonyl-2-methoxypyridin- 3-yl)-[4-(3,δ-dichlorophenyl)piperazin-l-yl]iminothiolate l-[(6-Ethyl-δ-methoxycarbonyl-2-methoxypyridin-3-yl)aminothio- carbonyl]-4-(3,δ-dichlorophenyl)piperazine was reacted by the same way 20 with the example 199 to obtain the titled compound. yield : 90.5% Example 238) Methyl N-(6-ethyl-5-methoxycarbonyl-2-methoxypyridin- 3-yl) - [4- (2-methylthiophenyl)piperazin- 1 -yDiminothiolate l-[(6-Ethyl-δ-methoxycarbonyl-2-methoxypyridin-3-yl)aminothio- 25 carbonyl] -4- (2-methylthiophenyl)piperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 92.0% Example 239) Methyl N-(6-ethyl-5-methoxycarbonyl-2-methoxypyridin- 3-yl)-[4-(3,δ-diethylisophthalate-l-yl)piperazin-l-yl]iminothi-olate 30 l-[(6-Ethyl-δ-methoxycarbonyl-2-methoxypyridin-3-yl)aminothio- carbonyl]-4-(3,δ-diethylisophthalate-l-yl)piperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 93.2% Example 240) Methyl N-(6-ethyl-δ-methoxycarbonyl-2-methoxypyridin- 3-yl)-[4-(3,δ-difluorophenyl)piperazin-l-yl]iminothiolate δ 1 - [(6-Ethyl-5-methoxycarbonyl-2-methoxypyridin-3-yl)aminothio- carbonyl]-4-(3,δ-difluorophenyl)piperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 95.2% Example 241) Methyl 10 N-(2-methoxyquinolin-3-yl)-[4-(3,5-dimethoxyphe-nyl)piperazin-l-yl]- iminothiolate l-[(2-Methoxyquinolin-3-yl)aminothiocarbonyl]-4-(3,δ-dimethoxy- phenyDpiperazine was reacted by the same way with the example 199 to obtain the titled compound, lδ yield : 90.3% Example 242) Methyl N- (2-methoxyquinolin-3-yl) - [4- (3,δ-dimethylphenyl)piperazin- 1 -yl] - iminothiolate l-[(2-Methoxyquinolin-3-yl)aminothiocarbonyl]-4-(3,δ-dimethyl- 20 phenyDpiperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 91.1% Example 243) Methyl N-(2-methoxyquinolin-3-yl)-[4-(3,δ-difluoro- phenyDpiperazin- 1 -yDiminothiolate 2δ l-[(2-Methoxyquinolin-3-yl)aminothiocarbonyl]-4-(3,δ-difluorophenyl) -piperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 94.2% Example 244) Methyl 30 N-(2-methoxyquinolin-3-yl)-[4-(2-methoxyphenyl)- piperazin-1 -yDiminothiolate l-[(2-Methoxyquinolin-3-yl)aminothiocarbonyl]-4-(2-methoxyphenyl)- piperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 92.4% δ Example 24δ) Methyl N- (2-methoxyquinolin-3-yl) - [4- (3-chlorophenyl)pi-perazine- 1 -yl] - iminothiolate l-[(2-Methoxyquinolin-3-yl)aminothiocarbonyl]-4-(3-chlorophenyl)- piperazine was reacted by the same way with the example 199 to obtain 10 the titled compound. yield : 90.3% Example 246) Methyl N- (4,δ-dimethyl-2-methoxyphenyl- 1 -yl) - (4-phenyl-piperazin- 1 -yD ¬ iminothiolate lδ l-[(4,δ-Dimethyl-2-methoxyphenyl-l-yl)aminothiocarbonyl]-4-phenyl- piperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 9δ.4% Example 247) Methyl 20 N- (4,δ-dimethyl-2-methoxyphenyl- 1 -yl) - [4- (4-methylphenyl)- piperazin- 1 -yDiminothiolate l-[(4,δ-Dimethyl-2-methoxyphenyl-l-yl)aminothiocarbonyl]-4-(4- methylphenyDpiperazine was reacted by the same way with the example 199 to obtain the titled compound. 25 yield : 94.4% Example 248) Methyl N-(4,5-dimethyl-2-methoxyphenyl-l-yl)-[4-(2- ethylphenyl)piperazin-l-yl]iminothiolate 1 - [ (4,δ-Dimethyl-2-methoxyphenyl- 1 -yDaminothiocarbonyl] -4- (2-ethylphenyl)piperazine was reacted by the same way with the 30 example 199 to obtain the titled compound. yield : 96.2% Example 249) Methyl N- (4,δ-dimethyl-2-methoxyphenyl- 1-yl) - [4- (3,δ-di-methylphenyl) - piperazin- 1 -yl] iminothiolate 1 - [ (4,δ-Dimethyl-2-methoxyphenyl- 1 -yDaminothiocarbonyl] -4- (3,δ- δ dimethylphenyDpiperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 96.8% Example 2δ0) Methyl N-(4,5-dimethyl-2-methoxyphenyl-l-yl)-[4-(3,5-dimethoxy- 10 phenyDpiperazin- 1 -yDiminothiolate 1 - [ (4,δ-Dimethyl-2-methoxyphenyl- 1 -yDaminothiocarbonyl] -4- (3,5-dimethoxyphenyl)piperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 9δ.7% lδ Example 251) Methyl N- (4,5-dimethyl-2-methoxyphenyl- 1 -yl) - [4- (3,δ-difluorophenyl)- piperazin-l-yl]iminothiolate 1- [(4,5-Dimethyl-2-methoxyphenyl- l-yl)aminothiocarbonyl] -4- (3,δ-difluorophenyl)piperazine was reacted by the same way with the 20 example 199 to obtain the titled compound. yield : 90.4% Example 2δ2) Methyl N- (4,δ-dimethyl-2-methoxyphenyl- 1 -yl) - [4- (3-chlorophenyl) - piperazin-l-yl]iminothiolate 2δ 1 - [(4,δ-Dimethyl-2-methoxyphenyl- 1 -yDaminothiocarbonyl] -4- (3-chlorophenyl)piperazine was reacted by the same way with the example 199 to obtain the titled compound. yield : 94.2% Example 2δ3) Methyl 30 N- (4,δ-dimethyl-2-methoxyphenyl- 1 -yl) - [4- (3-bromophenyl) - piperazin-l-yl]iminothiolate 1 - [(4,δ-Dimethyl-2-methoxyphenyl- l-yl)aminothiocarbonyl] -4- (3-bromophenyl)piperazine was reacted by the same way with the example 199 to obtain the titled compound, yield : 94.4% δ Example 254) Methyl N- (4,5-dimethyl-2-methoxyphenyl- 1 -yl) - [4- (2-methylthiophenyl) - piperazin- 1 -yDiminothiolate l-[(4,δ-Dimethyl-2-methoxyphenyl-l-yl)aminothiocarbonyl]-4- (2-methylthiophenyl)piperazine was reacted by the same way with the 10 example 199 to obtain the titled compound, yield : 93.δ% Physical data of the compounds prepared in the above examples are as follows : lδ Example 1 1H NMR(CDCb) : δ 2.37(3H,s), 2.39(3H,s), 3.27(4H,t), 3.74(4H,t), 3.97(3H,s), 6.97(2H,m), 7.31 (2H,t) Example 2 1H NMR(CDCls) : δ 2.36(3H,s), 2.40(3H,s), 313(4H,t), 3.7δ(4H,t), 3.89(3H,s), 3.97(3H,s), 6.9δ(3H,m), 7.05(2H,m) 20 Example 3 1H NMR(CDCls) : δ 2.37(3H,s), 2.39(3H,s), 3.25(4H,t), 3.71 (4H,t), 3.79(6H,s), 3.97(3H,s), 610(3H,m) Example 4 1H NMR(CDCls) : δ 1.26(3H,t), 2.37(3H,s), 2.41 (3H,s), 2.74(2H,q), 2.94(4H,t), 3.68(4H,t), 3.97(3H,s), 6.72(lH,brs), 7.08(2H,m), 719(lH,t), 7.2δ(lH,s) 2δ Example δ 1H NMR(CDCls) : δ 0.92(3H,t), 1.3δ(2H,m), 1.57(2H,m), 2.37(3H,s), 2.39(3H,s), 2.56(2H,t), 3.2δ(4H,t), 3.78(4H,t), 3.97(3H,s), 6.9δ(2H,brs), 714(2H,m) Example 6 1H NMR(CDCls) : δ 1.23(6H,d), 2.38(3H,s), 2.42(3H,s), 2.9δ(4H,t), 3.53(lH,m), 3.72(4H,t), 3.98(3H,s), 711(lH,m), 7.29(lH,m) 30 Example 7 1H NMR(CDCls) ' • δ 2.30(6H,s), 2.37(3H,s), 2.40(3H,s), 3.2δ(4HJ), 3.75(4H,t), 3.97(3H,s), 6.62(3H,m) Example 8 1H NMR(CDCls) : δ 2.21(6H,s), 2.22(6H,s), 2.38(3H,s), 2.43(3H,s), 317(4HJ), 3.67(4H,t), 4.00(3H,s), 6.84dH,s) Example 9 1H NMR(CDCls) : δ 2.37(3H,s), 2.40(3H,s), 3.14(4H,t), 3.73(4HJ), 3.98(3H,s), 6.99(2H,m), 7.07(2H,m) Example 10 1H NMR(CDCls) : δ 2.37(3H,s), 2.39(3H,s), 3.26(4H,t), 3.70(4H,t), 3.98(3H,s), 6.85(lH,m), 7.01(lH,d), 7.05(lH,s), 713(lH,t) Example 11 1H NMR(CDCls) : δ 2.37(3H,s), 2.39(3H,s), 3.27(4H,t), 3.69(4H,t), 3.98(3H,s), 6.75(2H,s), 6.84(lH,s) Example 12 1H NMR(CDCls) : δ 2.37(3H,s), 2.39(3H,s), 3.27(4H,t). 3.69(4H,t), 3.97(3H,s), 6.30(lH,t), 6.37(2H,d) Example 13 1H NMR(CDCls) : δ 2.38(3H,s), 2.40(3H,s), 3.31(4H,s), 3.73(4H,t), 3.98(3H,s), 7.09(lH,d), 713(2H,m), 7.38(lH,t) Example 14 1H NMR(CDCls) : δ 2.38(3H,s), 2.42(3H,s), 2.43(3H,s), 3.0δ(4H,t), 3.73(4H,t), 3.99(3H,s), 7.05(lH,brs), 713(lH,s) Example 15 1H NMR(CDCb) : δ 2.39(3H,s), 2.45(3H,s), 3.57(4H,t), 3.88(4H,t), 4.08(3H,s), 7.98(2H,s), 8.45(lH,s) Example 16 1H NMR(CDCls) : δ 2.38(3H,s), 2.40(3H,s), 3.26(4H,t), 3.70(4H,t), 3.98(3H,s), 6.35(lH,s), 6.42(2H,s) Example 17 1H NMR(CDCls) : δ 2.38(3H,s), 2.40(3H,s), 2.δ4(3H,s), 3.46(4H,t), 3.74(4H,t), 3.99(3H,s), 6.88(2H,d), 7.90(2H,d) Example 18 1H NMR(CDCls) : δ 2.39(3H,s), 2.40(3H,s), 2.91(4H,t), 3.22(3H,s), 3.46(4H,t), 3.85(3H,s), 3.95(3H,s), 6.89(3H,m), 7.02(lH,m) Example 19 1H NMR(CDCls) : δ 2.39(3H,s), 2.40(3H,s), 3.01(4H,t), 3.21(3H,s), 3.40(4H,t), 3.7δ(6H,s), 3.92(3H,s), 6.03(3H,s) δ Example 20 1H NMR(CDCls) : δ 2.26(6H,s), 2.39(3H,s), 2.40(3H,s), 2.99(4H,t), 3.22(3H,s), 3.40(4H,t), 3.93(3H,s), 6.δ2(3H,m) Example 21 1H NMR(CDCls) : δ 2.40(3H,s), 2.41(3H,s), 3.03(4H,t), 3.21(3H,s), 3.38(4H,t), 3.93(3H,s), 6.68(2H,s), 6.81(lH,s) Example 22 1H NMR(CDCls) : δ 2.40(3H,s), 2.41(3H,s), 3.03(4H,t), 0 3.21(3H,s), 3.39(4H,t), 3.93(3H,s), 6.27(3H,m) Example 23 1H NMR(CDCls) : δ 2.40(9H,s), 2.87(4H,t), 3.22(3H,s), 3.46(4H,t), 3.96(3H,s), 7.02(lH,brs), 711(3H,s) Example 24 1H NMR(CDCls) : δ 2.43(6H,s), 3.24(3H,s), 3.27(4H,t), 3.4δ(4HJ), 3.9δ(3H,s), 7.89(2H,d), 8.40(lH,s) Example 2δ 1H NMR(CDCls) : δ 2.38(3H,s), 2.39(3H,s), 2.9δ(4HJ), 5 3.21(3H,s), 3.37(4HJ), 3.92(3H,s), δ.62(lH,s), δ.6δ(2H,s) Example 26 1H NMR(CDCb) : δ 1.6δ(3H,t), 2.39(3H,s), 2.40(3H,s), 2.96(4H,t), 3.35(4H,t), 3.74(2H,q), 3.75(6H,s), 3.92(3H,s), 6.02(3H,s) Example 27 1H NMR(CDCb) : δ 117(3H,t), 2.25(6H,s), 2.39(3H,s), 2.40(3H,s), 2.95(4H,t), 3.36(4H,t), 3.74(2H,q), 3.92(3H,s), 6.δO(3H,m) 10 Example 28 1H NMR(CDCb) : δ 2.32(3H,s), 2.34(3H,s), 3.34(4H,t), 3.78(6H,s), 3.98(3H,s), 4.07(4H,t). 612(3H,m) Example 29 1H NMR(CDCb) : δ 1.26(3H,t), 2.3δ(3H,s), 2.37(3H,s), 2.74(2H,q), 3.02(4H,t), 3.97(3H,s), 4.02(4H,t), 7.09(2H,q), 719(lH,t), 7.5δ(lH,s) lδ Example 30 1H NMR(CDCb) : δ 2.29(6H,s), 2.32(3H,s), 2.3δ(3H,s), 3.31 (4H,t), 3.98(3H,s), 4.04(4H,t), 6.δ9(3H,brs) Example 31 1H NMR(CDCb) : δ 2.32(3H,s), 2.3δ(3H,s), 3.33(4H,t), 3.98(3H,s), 4.06(4H,t), 6.82(lH,d), 7.01(2H,m), 713(lH,t) Example 32 1H NMR(CDCb) : δ 2.44(3H,s), 2.49(3H,s), 3.48(4H,t), 20 4.05(3H,s), 4.25(4H,t), 6.98(3H,m) Example 33 1H NMR(CDCb) : δ 2.35(3H,s), 2.36(3H,s), 2.43(3H,s), 3.12(4H,t), 3.97(3H,s), 4.0δ(4H,t), 6.87(lH,d), 7.05(lH,brs), 713(2H,m) Example 34 1H NMR(CDCb) : δ 1.26(6H,m), 2.30(6H,s), 2.70(2H,t), 2.78(2H,t), 3.2δ(4H,t), 3.74(4H,t), 3.99(3H,s), 6.6δ(3H,m) 2δ Example 3δ 1H NMR(CDCb) : δ 1.24(6H,m), 2.69(2H,t), 2.78(2H,t), 3.24(4H,t), 3.71(4H,t), 3.78(6H,s), 3.98(3H,s), 6.07(lH,s), 611(2H,brs) Example 36 1H NMR(CDCb) : δ 3.34(4H,t), 3.88(4H,t), 41δ(3H,s), 7.05(3H,m), 7.35(3H,m), 7.43(2H,m), 7.70(lH,brs) Example 37 1H NMR(CDCb) : δ 317(4H,t), 3.83(4H,t), 3.90(3H,s), 30 416(3H,s), 6.99(4H,m), 7.49(2H,m), 7.7δ(2H,m) Example 38 1H NMR(CDCb) : δ 3.22(4H,t), 3.30(4H,t), 3.79(6H,s), 4.1K3H-S), 7.20(lH,d), 7.33(2H,m), 7.50(2H,m), 7.62(lH,d), 7.76(lH,m), 7.83(lH,m) Example 39 1H NMR(CDCb) : δ 1.28(3HJ), 2.78(2H,q), 3.02(4HJ), 3.89(4H,t), 415(3H,s), 713(2H,m), 7.21(lH,t), 7.28(lH,m), 7.43(3H,m), δ 7.70(lH,d) Example 40 1H NMR(CDCb) : δ 1.24(6H,d), 2.98(4H,t), 3.δ6(lH,m), 3.82(4H,t), 41δ(3H,s), 716(3H,m), 7.30(lH,d), 7.43(2H,brs), 7.69(2H,d) Example 41 1H NMR(CDCb) : δ 0.93(3H,t), 1.3δ(2H,m), l.δ7(2H,m), 2.56(2HJ), 3.3δ(4H,t), 3.88(4H,t), 41δ(3H,s), 719(3H,brs), 7.43(3H,brs), 0 7.70(2H,brs) Example 42 1H NMR(CDCb) : δ 2.30(6H,s), 3.26(4H,t), 3.78(4H,t), 414(3H,s), 6.60(3H,s), 7.30(2H,m), 7.δO(lH,s), 7.5δ(lH,m) Example 43 1H NMR(CDCb) : δ 2.21 (6H,s), 2.34(6H,s), 3.20(4H,t), 3.83(4H,t), 417(3H,s), 6.85(lH,s), 7.46(2H,m), 7.61(lH,brs), 7.72(lH,d) 5 Example 44 1H NMR(CDCb) : δ 3.20(4H,t), 3.91 (4H,t), 415(3H,s), 7.07(4H,m), 7.42(3H,m), 7.70(lH,d) Example 4δ 1H NMR(CDCb) : δ 3.30(4H,t), 3.90(4H,t), 416(3H,s), 6.9δ(lH,d), 7.0δ(lH,d), 71δ(2H,m), 7.42(2H,m), 7.δ3(lH,s), 7.69(lH,d) Example 46 1H NMR(CDCb) : δ 3.27(4H,t), 3.78(4HJ), 416(3H,s), 0 6.39(3H,m), 7.δ2(2H,m), 7.74(2H,m) Example 47 1H NMR(CDCb) : δ 3.34(4H,t), 3.90(4H,t), 416(3H,s), 71δ(3H,m), 7.40(3H,m), 7.52(lH,brs), 7.70(lH,d) Example 48 1H NMR(CDCb) : δ 3.δδ(4H,t), 3.98(4H,t), 419(3H,s), 7.46(3H,m), 7.73(lH,m), 8.00(2H,s), 8.44(lH,s) δ Example 49 1H NMR(CDCb) : δ 3.2δ(4H,t), 3.73(4H,t), 413(3H,s), 5.68(lH,brs), 5.79(2H,brs), 7.49(2H,m), 7.74(2H,m) Example δO 1H NMR(CDCb) : δ 2.54(3H,s), 3.49(4H,t), 3.92(4H,t), 416(3H,s), 6.95(2H,d), 7.43(2H,m), 7.δl(lH,brs), 7.71(lH,d), 7.92(2H,d) Example δl 1H NMR(CDCb) : δ 2.47(3H,s), 3.30(4H,t), 4.04(4H,t), 0 419(3H,s), 7.20(3H,brs), 7.47(2H,m), 7.60(2H,m), 7.76(lH,m) Example δ2 1H NMR(CDCb) : δ 2.92(4H,t), 3.δ7(4H,t), 411(3H,s), 71δ(lH,d), 712(lH,t), 7.30(4H,m), 7.41(4H,m), 7.54(lH,m), 7.64(3H,m) Example 53 1H NMR(CDCb) : δ 319(4HJ), 3.38(3H,s), 3.68(4H,t), 3.78(6H,s), 4.07(3H,s), 6.09(3H,brm), 7.50(2H,m), 7.80(2H,m) Example δ4 1H NMR(CDCb) : δ 3.08(4H,t), 3.39(3H,s), 3.73(4H,t), δ 3.88(3H,s), 4.09(3H,s), 6.92(4H,m), 7.δO(2H,m), 7.80(2H,m) Example δδ 1H NMR(CDCb) : δ 2.30(6H,s), 3.19(4H,t), 3.39(3H,s), 3.70(4H,t), 4.08(3H,s), 6.δ9(3H,brs), 7.δ2(2H,s), 7.80(2H,m) Example δ6 1H NMR(CDCb) : δ 3.20(4H,t), 3.39(3H,s), 3.66(4H,t), 4.07(3H,s), 6.3δ(3H,m), 7.δ2(2H,m), 7.82(2H,m) 10 Example δ7 1H NMR(CDCb) : δ 3.41(3H,s), 3.43(4H,t), 3.71(4H,t), 4.09(3H,s), 7.δδ(2H,m), 7.79(lH,m), 7.88(lH,m), 7.96(2H,s), 8.44(lH,s) Example δ8 1H NMR(CDCb) : δ 3.13(4H.t), 3.37(3H,s), 3.6δ(4H,t), 3.94(3H,s), 5.δ9(2H,m), 5.61(lH,s), 7.50(2H,m), 7.77(lH,m), 7.82(lH,m) Example δ9 1H NMR(CDCb) : δ 1.33(3H,t), 31δ(4H,t), 3.65(4H,t), lδ 3.77(6H,s), 3.91(2H,q), 4.08(3H,s), 6.09(3H,brs), 7.δ2(2H,m), 7.80(2H,m) Example 60 1H NMR(CDCb) : δ 1.34(3H,t), 2.28(6H,s), 312(4H,t), 3.62(4H,t), 3.91(2H,q), 4.08(3H,s), 6.δ5(3H,brs), 7.51(2H,m), 7.80(2H,m) Example 61 1H NMR(CDCb) : δ 1.33(3H,t), 31δ(4H,t), 3.6K4HJ), 3.91(2H,q), 4.08(3H,s), 6.77(2H,s), 6.87(lH,s), 7.53(2H,m), 7.78(lH,m), 20 7.8δ(lH,m) Example 62 1H NMR(CDCb) : δ 1.43(6H,d), 2.98(4H,t), 3.48(4H,d), 3.74(6H,s), 4.06(3H,s), 4.71(lH,m), δ.99(2H,s), 6.01(lH,s), 7.δ3(2H,m), 7.77(lH,m), 7.84(lH,m) Example 63 1H NMR(CDCb) : δ 3.49(4H,t), 3.96(3H,s), 41δ(3H,s), 2δ 4.31(4H,t), 7.06(3H,m), 7.44(3H,m), 7.71(2H,d) Example 64 1H NMR(CDCb) : δ 3.40(4HJ), 3.80(6H,s), 41δ(3H,s), 4.30(4H,t), 616(3H,brs), 6.84(lH,d), 7.23(lH,t), 7.44(2H,brs), 7.70dH,brs) Example 6δ 1H NMR(CDCb) : δ 1.27(3H,t), 2.76(2H,q), 3.0δ(4HJ), 41δ(3H,s), 4.39(4H,t), 710(2H,m), 719(lH,s), 7.40(3H,m), 7.7δ(lH,m), 30 8.01 (lH,s) Example 66 1H NMR(CDCb) : δ 2.31(6H,s), 3.36(4H,t), 414(3H,s), 4.38(4H,t), 6.64(3H,brs), 7.4δ(2H,m), 7.72(2H,m) Example 67 1H NMR(CDCb) : δ 3.34(4H,t), 416(3H,s), 4.38(4H,t), 6.85(lH,d), 7.01(lH,d), 7.06(lH,s), 71δ(lH,m), 7.42(3H,m), 7.68(lH,brs) Example 68 1H NMR(CDCb) : δ 3.42(4H,t), 416(3H,s), 4.30(4H f t). δ 6.39(3H,m), 7.20(lH,t), 7.43(lH,m), 7.69(2H,m) Example 69 1H NMR(CDCb) : δ 2.46(3H,s), 3.20(4H,t), 41δ(3H,s), 4.30(4H,t), 6.90(lH,m), 71δ(3H,m), 7.4δ(lH,m), 7.6δ(lH,t), 7.73(lH,m), 8.01 (lH,d) Example 70 1H NMR(CDCb) : δ 2.δ6(3H,s), 3.60(4H,t), 415(3H,s), 10 4.30(4H,t), 6.96(2H,d), 7.44(lH,m), 7.δ9(lH,m), 7.74(2H,m), 7.9δ(2H,m) Example 71 1H NMR(CDCb) : δ 0.92(3H,t), 1.3δ(2H,m), 1.57(2H,m), 2.δ6(2H,t), 3.34(4H,t), 411(4H,t), 419(3H,s), 6.91(2H,m), 714(2H,m), 7.60(lH,t), 7.68(lH,t), 7.98(lH,d), 8.02(lH,d) Example 72 1H NMR(CDCb) : δ l.δ2(3H,t), 3.32(4H,t), 3.79(6H,s), lδ 3.80(4H,t), 4.60(2H,q), 614(3H,m), 7.44(2H,brs), 7.69(2H,brs) Example 73 1H NMR(CDCb) : δ l.δO(3H,t), 3.26(4H,t), 3.86(4H,t), 411(2H,q), 4.62(2H,q), 6.9δ(2H,m), 7.07(lH,brs), 7.δδ(3H,m), 7.80(2H,m) Example 74 1H NMR(CDCb) : δ l.δ2(3H,t), 2.30(6H,s), 3.30(4H,t), 3.80(4H,t), 4.61(2H,q), 6.62(3H,brs), 7.48(2H,m), 7.76(2H,m) 20 Example 75 1H NMR(CDCb) : δ 1.52(3H,t), 2.27(3H,s), 2.29(3H,s), 2.98(4H,t), 3.78(4H,t), 4.60(2H,q), 6.94(2H,m), 710(lH,m), 7.30(lH,brs), 7.47(2H,brs), 7.74(lH,brs) Example 76 1H NMR(CDCb) : δ 1.28(3H,t), 1.52(3H,t), 2.79(2H,q), 3.06(4H,t), 3.89(4H,t), 4.61(2H,q), 714(2H,m), 7.22(lH,t), 7.28(lH,d), 25 7.44(2H,m), 7.69(2H,m) Example 77 1H NMR(CDCb) : δ 1.54(3H,t), 3.36(4H,t), 3.91 (4H,t), 4.63(2H,q), 6.88(2H,s), 6.90(lH,s), 7.47(2H,m), 7.δ9(lH,brs), 7.71(lH,m) Example 78 1H NMR(CDCb) : δ l.δ2(3H,t), 3.30(4H,t), 3.83(4HJ), 4.60(2H,q), 6.90(lH,d), 7.03(lH,d), 710(lH,s), 71δ(lH,t), 7.43(2H,brs), 30 7.69(lH,brs) Example 79 1H NMR(CDCb) : δ l.δ2(3HJ), 3.33(4H,t), 3.77(4H,t), 3.78(4H,t), 4.68(2H,q), 6.3K1HJ), 6.40(2H,d), 7.47(2H,m), 7.54(lH,m), 7.72(lH,t) Example 80 1H NMR(CDCb) : δ 1.52(3H,t), 2.44(3H,s), 313(4HJ), 3.89(4HJ), 4.61 (2H,q), 71δ(4H,brs), 7.4δ(2H,m), 7.69(2H,brm) δ Example 81 1H NMR(CDCb) : δ 1.44(3HJ), 3.22(4H,t), 3.38(3H,s), 3.71(4H,t), 3.78(6H,s), 4.δ3(2H,q), 6.09(lH,brs), 613(2H,brs), 7.δO(2H,m), 7.7δ(lH,m), 7.82(lH,m) Example 82 1H NMR(CDCb) : δ 1.43(3H,t), 3.22(4H,t), 3.38(3H,s), 3.66(4H,t), 4.54(2H,q), 6.76(2H,s), 6.86(lH,s), 7.51(2H,m), 7.76(lH,m), 0 7.83(lH,m) Example 83 1H NMR(CDCb) : δ 1.34(3H,t), 1.44(3H,t), 31δ(4H,t), 3.62(4H,t), 3.77(6H,s), 3.91(2H,q), 4.δ3(2H,q), 6.06(3H,brs), 7.51(2H,m), 7.75(lH,m), 7.81(lH,m) Example 84 1H NMR(CDCb) : δ 1.33(3H,t), 1.44(3H,t), 316(4H,t), 5 3.59(4H,t), 3.91(2H,q), 4.54(2H,q), 6.74(2H,s), 6.85dH,s), 7.δ2(2H,m), 7.76(lH,m), 7.82(lH,m) Example 85 1H NMR(CDCb) : δ 1.34(3H,t), 1.45(3H,t), 2.28(6H,s), 315(4H,t), 3.63(4H,t), 3.91(2H,q), 4.53(2H,q), 6.56(3H,brs), 7.δO(2H,m), 7.7δ(lH,d), 7.82(lH,d) 0 Example 86 1H NMR(CDCb) : δ 2.30(6H,s), 3.27(4H,t), 3.73(4H,t), 4.03(3H,s), 6.60(3H,brs), 713(lH,s), 7.33(2H,t), 7.4δ(lH,s), 7.67(lH,m), 7.7δ(lH,m) Example 87 1H NMR(CDCb) : δ 3.20(4H,t), 3.40(4H,t), 3.7δ(6H,s), 3.99(3H,s), 610(3H,brs), 712(lH,s), 7.3K2HJ), 7.44(lH,s), 7.65(lH,m), δ 7.70(lH,m) Example 88 1H NMR(CDCb) : δ 3.32(4HJ), 3.73(4H,t), 4.03(3H,s), 6.32(lH,t), 6.41(2H,d), 713(lH,s), 7.34(2H,t), 7.43(lH,s), 7.67(lH,m), 7.7δ(lH,m) Example 89 1H NMR(CDCb) : δ 3.34(4H,t), 3.77(4H,t), 4.03(3H,s), 0 6.84(lH,m), 6.92(2H,m), 713(lH,s), 7.34(2H,m), 7.43(lH,s), 7.68(lH,m), 7.7δ(lH,m) Example 90 1H NMR(CDCb) : δ 2.20(6H,s), 2.85(4H,t), 318(3H,s), 3.32(4H,t), 3.99(3H,s), 6.39(2H,s), 6.47(lH,s), 7.20(lH,s), 7.3δ(lH,t), 7.43(lH,t), 7.δ3(lH,s), 7.69(lH,d), 7.73(lH,d) Example 91 1H NMR(CDCb) : δ 2.91(4H,t), 318(3H,s), 3.33(4H,t), δ 4.00(3H,s), 6.24(3H,brm), 7.21(lH,s), 7.37(1HJ), 7.4δ(lHJ), 7.53(lH,s), 7.70(lH,d), 7.74(lH,d) Example 92 1H NMR(CDCb) : δ 3.03(4H,t), 318(3H,s), 3.52(4H,t), 4.01(3H,s), 6.82(3H,brm), 712(lH,brs), 7.37(lH,m), 7.46(lH,m), 7.56(lH,m), 7.72(2H,m) 0 Example 93 1H NMR(CDCb) ' • δ 2.88(4H,t), 318(3H,s), 3.33(4H,t), 3.71(6H,s), 3.99(3H,s), δ.92(2H,brs), δ.97(lH,brs), 7.20(lH,s), 7.36(lH,t), 7.43(lH,t), 7.52(lH,s), 7.69(lH,d), 7.73(lH,d) Example 94 1H NMR(CDCb) : δ 1.34(3H,t), 2.21 (6H,s), 2.88(4H,t), 3.32(4H,t), 3.91(2H,q), 3.99(3H,s), 6.39(2H,s), 6.47(lH,s), 7.20(lH,s), 5 7.35(lH,t), 7.46(lH,t), 7.δ6(lH,s), 7.71(lH,d), 7.73(lH,d) Example 95 1H NMR(CDCb) : δ 1.35(3HJ), 2.90(4H,t), 3.33(4H,t), 3.70(6H,s), 3.92(2H,q), 3.99(3H,s), 5.92(2H,brs), 5.97(lH,brs), 7.25(lH,s), 7.36(lH,t), 7.43(lH.t), 7.52(lH,s), 7.72dH,d), 7.73(lH,d) Example 96 1H NMR(CDCb) : δ 214(3H,s), 2.33(3H,s), 319(4H,s), 0 3.20(4H,s), 3.98(3H,s), 6.84(lH,s), 6.87(lH,t), 6.93(2H,d), 7.25(lH,d), 7.55(lH,s) Example 97 1H NMR(CDCb) : δ 213(3H,s), 2.27(3H,s), 2.32(3H,s), 313(4H,d), 319(4H,d), 3.98(3H,s), 6.81(lH,s), 6.83(2H,d), 7.07(2H,d), 7.54(lH,s) δ Example 98 1H NMR(CDCb) : δ 0.91(3H,t), 1.30(2H,m), 1.54(2H,m), 213(3H,s), 2.32(3H,s), 2.53(2H,t), 314(4H,d), 319(4H,d), 3.98(3H,s), 6.80(lH,s), 6.8δ(2H,d), 7.08(2H,d), 7.δδ(lH,s) Example 99 1H NMR(CDCb) : δ 213(3H,s), 2.27(6H,s), 2.32(3H,s), 312(4H,s), 313(4H,s), 3.89(3H,s), 6.56(3H,s), 6.81(lH,s), 7.δ4(lH,s) 0 Example 100 1H NMR(CDCb) : δ 216(3H,s), 2.33(3H,s), 3.08(4H,t), 3.2δ(4H,t), 3.8δ(3H,s), 3.98(3H,s), 6.87(lH,t), 6.93(2H,d), 7.02(lH,m), 7.57QH.S) Example 101 1H NMR(CDCb) : δ 214(3H,s), 2.32(3H,s), 317(8H,s), 3.77(6H,s), 3.98(3H,s), 6.04(lH,s), 6.08(2H,s), 6.81(lH,s), 7.δ3(lH,s) Example 102 1H NMR(CDCb) : δ 21δ(3H,s), 2.33(3H,s), 317(8H,s), δ 3.98(3H,s), 6.28(lH,t), 6.3δ(2H,d), 6.78(lH,s), 7.50dH,s) Example 103 H NMR(CDCb) : δ 216(3H,s), 2.39(3H,s), 318(4H,s), 3.20(4H,s), 3.98(3H,s), 6.69(3H,s), 6.78(lH,s), 7.45(lH,s) Example 104 1H NMR(CDCb) : δ 21δ(3H,s), 2.33(3H,s), 318(8H,s), 3.98(3H,s), 6.78(lH,s), 6.82(lH,d), 6.97(lH,d), 7.03(lH,s), 7.1K1HJ), 10 7.δl(lH,s) Example lOδ 1H NMR(CDCb) : δ 216(3H,s), 2.34(3H,s), 3.20(4H,s), 3.37(4H,s), 3.90(3H,s), 6.78(lH,s), 7.47(lH,s), 7.97(2H,s), 8.42(lH,s) Example 106 1H NMR(CDCb) : δ 1.40(6H,t), 217(3H,s), 2.30(3H,s), 3.29(4H,s), 3.33(4H,s), 3.98(3H,s), 4.38(4H,q), 7.41(lH,s), 7.72(2H,s), lδ 816(lH,s) Example 107 1H NMR(CDCb) : δ 214(3H,s), 2.33(3H,s), 3.21(8H,s), 3.98(3H,s), 4.66(4H,s), 6.82(lH,s), 6.88(3H,s), 7.δ2(lH,s) Example 108 1H NMR(CDCb) : δ 119(3H,t), 2.36(3H,s), 2.52(2H,q), 3.07(4H,s), 3.30(4H,s), 3.84(3H,s), 3.97(3H,s), 6.85-7.03 (5H,m), 7.51(lH,s) 20 Example 109 1H NMR(CDCb) : δ 114(3H,t), 2.36(3H,s), 2.50(2H,q), 317(8H,d), 3.77(6H,s), 3.98(3H,s), 6.04(lH,s), 6.07(2H,s), 6.80(lH,s), 7.δ6(lH,s) Example 110 1H NMR(CDCb) : δ 1.22(6H,m), 2.36(3H,s), 2.δ4(2H,q), 2.68(2H,q), 2.90(4H,s), 3.20(4H,s), 3.98(3H,s), 6.80(lH,s), 7.08(2H,m), 25 717(lH,t), 7.22(lH,d), 7.62(lH,s) Example 111 1H NMR(CDCb) : δ 114(3HJ), 2.36(3H,s), 2.50(2H,q), 318(4H,s), 3.25(4H,s), 3.98(3H,s), 6.89(4H,m), 7.27(2H,m), 7.52(lH,s) Example 112 1H NMR(CDCb) : δ 1.20(3H,t), 2.36(3H,s), 2.38(3H,s), 2.54(2H,q), 3.00(4H,s), 3.27(4H,s), 3.97(3H,s), 7.00(lH,brs) 7.01(lH,s), 30 710(3H,s), 7.55(lH,s) Example 113 1H NMR(CDCb) : δ 1.14(3H,t), 2.27(6H,s), 2.36(3H,s), 2.49(2H,q), 317(4H,s), 318(4H,s), 3.98(3H,s), 6.55(3H,s), 6.81(lH,s), 7.57(lH,s) Example 114 1H NMR(CDCb) : δ llδ(3H,t), 2.36(3H,s), 2.50(2H,q), 317(8H,s), 3.98(3H,s), 6.28(lH,t), 6.3δ(2H,d), 6.6δ(lH,brs), 6.78(lH,s), δ 7.δ2(lH,s) Example llδ 1H NMR(CDCb) : δ 1.15(3H,t), 2.36(3H,s), 2.50(2H,q), 317(8H,s), 3.98(3H,s), 617(lH,brs), 6.74(3H,m), 6.82(lH,s), 7.51(lH,s) Example 116 1H NMR(CDCb) : δ 115(3H,t), 2.32(3H,s), 2.48(2H,q), 2.84(4H,s), 2.94(4H,s), 3.94(3H,s), 6.73(lH,s), 7.00(lH,s), 7.09(lH,t), 10 7.24(2H,m), 7.29(lH,t), 7.3δ(2H,t), 7.δl(lH,s), 7.δ8(2H,d) Example 117 1H NMR(CDCb) : δ 1.15(3H,t), 2.37(3H,s), 2.δl(2H,q), 3.28(4H,s), 3.39(4H,s), 3.98(3H,s), 6.84(lH,brs), 7.47(lH,s), 7.96(2H,s), 8.42(lH,s) Example 118 1H NMR(CDCb) : δ 2.69(3H,s), 3.20(8H,s), 3.77(6H,s), lδ 3.80(3H,s), 4.06(3H,s), 6.04(lH,s), 6.09(2H,s), 6.93(lH,s), 8.39(lH,s) Example 119 1H NMR(CDCb) : δ 2.28(6H,s), 2.70(3H,s), 3.20(8H,s), 3.80(3H,s), 4.06(3H,s), 6.δ6(3H,s), 6.94(lH,s), 8.40(lH,s) Example 120 1H NMR(CDCb) : δ 2.69(3H,s), 319(4H,d), 3.22(4H,d), 3.80(3H,s), 4.07(3H,s), 6.29(lH,t), 6.36(2H,d), 6.7δ(lH,brs), 6.93(lH,s), 20 8.36(lH,s) Example 121 1H NMR(CDCb) : δ 2.70(3H,s), 313(4H,s), 3.28(4H,s), 3.83(3H,s), 3.86(3H,s), 4.06(3H,s), 6.94(δH,m), 8.42(lH,s) Example 122 1H NMR(CDCb) : δ 2.70(3H,s), 3.23(8H,s), 3.78(3H,s), 4.07(3H,s), 6.89(lH,t), 6.94(2H,d), 6.99(lH,brs), 7.27(2H,d), 8.38(lH,s) 2δ Example 123 1H NMR(CDCb) : δ 2.27(3H,s), 2.69(3H,s), 317(4H,d), 3.22(4H,d), 3.78(3H,s), 4.06(3H,s), 6.84(2H,d), 6.98(lH,brs), 7.09(lH,d), 8.38(lH,s) Example 124 1H NMR(CDCb) : δ 2.70(3H,s), 3.22(8H,s), 3.80(3H,s), 4.06(3H,s), 6.78(lH,d), 6.84(lH,d), 6.88(lH,s), 6.98(lH,brs), 717(lH,t), 30 8.3δ(lH,s) Example 12δ 1H NMR(CDCb) : δ 2.39(3H,s), 317(8H,s), 3.76(6H,s), 4.00(3H,s), 4.59(2H,s), 6.03(lH,s), 6.07(2H,d), 6.88(lH,s), 7.79(lH,s) Example 126 1H NMR(CDCb) : δ 2.27(6H,s), 2.40(3H,s), 318(8H,s), 4.01 (3H,s), 4.δ9(2H,s), 6.δδ(3H,s), 6.87(lH,s), 7.80(2H,s) Example 127 1H NMR(CDCb) : δ 2.40(3H,s), 319(8H,s), 4.00(3H,s), δ 4.61(2H,s), 6.27(lH,t), 6.3δ(2H,d), 6.86(lH,s), 7.79(lH,s) Example 128 1H NMR(CDCb) : δ 2.40(3H,s), 3.08(4H,s), 3.31(4H,s), 3.84(3H,s), 3.99(3H,s), 4.61(2H,s), 6.92(δH,m), 7.77(lH,s) Example 129 1H NMR(CDCb) : δ 2.39(3H,s), 3.20(8H,d), 4.00(3H,s), 4.δ8(2H,s), 6.90(4H,m), 7.27(2H,d), 7.79(lH,s) 10 Example 130 1H NMR(CDCb) : δ 217(3H,s), 2.39(3H,s), 313(4H,d), 3.22(4H,d), 3.99(3H,s), 4.58(2H,s), 6.82(2H,d), 7.00(lH,brs), 7.06(2H,d), 7.78(lH,s) Example 131 1H NMR(CDCb) : δ 2.39(3H,s), 319(8H,d), 4.00(3H,s), 4.60(2H,s), 6.76(lH,d), 6.82(lH,d), 6.85(lH,s), 6.9δ(lH,brs), 716(lH,t), lδ 7.77(lH,s) Example 132 1H NMR(CDCb) : δ 2.27(6H,s), 2.δO(3H,s), 2.64(3H,s), 319(8H,d), 4.07(3H,s), 6.δδ(2H,s), 6.56(lH,s), 6.88(lH,s), 7.39(lH,brs), 819(lH,s) Example 133 1H NMR(CDCb) : δ 2.50(3H,s), 2.64(3H,s), 316(4H,s), 20 3.2δ(4H,s), 3.76(6H,s), 4.06(3H,s), 6.0δ(lH,s), 6.07(2H,s), 7.0δ(lH,brs), 813(lH,s) Example 134 1H NMR(CDCb) : δ 2.δ0(3H,s), 2.65(3H,s), 3.20(4H,s), 3.26(4H,s), 4.06(3H,s), 6.91(4H,m), 7.27(2H,m), 815(lH,s) Example 13δ 1H NMR(CDCb) : δ 218(3H,s), 2.42(3H,s), 2.57(3H,s), 25 315(4H,s), 3.30(4H,s), 4.07(3H,s), 6.84(2H,d), 7.07(3H,d), 813(lH,s) Example 136 1H NMR(CDCb) : δ 2.δ2(3H,s), 2.66(3H,s), 3.22(4H,s), 3.28(4H,s), 4.07(3H,s), 6.30(3H,m), 8.07(lH,s) Example 137 1H NMR(CDCb) : δ 2.39(3H,s), 2.58(3H,s), 2.66(3H,s), 3.04(4H,s), 3.33(4H,s), 4.07(3H,s), 7.02(lH,d), 710(3H,s), 814(lH,s) 30 Example 138 1H NMR(CDCb) : δ 1.40(3H,d), 2.26(6H,s), 2.39(3H,s), 319(8H,s), 3.99(3H,s), δ.04(lH,q), 6.δ4(3H,s), 6.86(lH,s), 7.93(lH,s) Example 139 1H NMR(CDCb) : δ 1.40(3H,d), 2.39(3H,s), 3.20(8H,m), 3.76(6H,s), 3.99(3H,s), δ.03(lH,q), 6.03(lH,s), 6.06(2H,s), 7.04(lH,brs), 7.89(lH,s) Example 140 1H NMR(CDCb) : δ 1.40(3H,d), 2.39(3H,s), 319(4H,m), δ 3.30(4H,s), 3.97(3H,s), δ.08(lH,q), 6.89(3H,m), 7.24(2H,m), 7.87(lH,s) Example 141 1H NMR(CDCb) : δ 1.40(3H,d), 2.26(3H,s), 2.39(3H,s), 31δ(4H,s), 3.3δ(4H,s), 3.97(3H,s), 5.02(lH,q), 6.82(2H,d), 7.06(2H,d), 7.84(lH,s) Example 142 1H NMR(CDCb) : δ 1.40(3H,d), 2.39(3H,s), 3.20(4H,m), 10 3.28(4H,s), 3.98(3H,s), δ.04(lH,q), 6.27(3H,m), 7.8δ(lH,s) Example 143 1H NMR(CDCb) : δ 1.4δ(3H,d), 2.38(3H,s), 2.39(3H,s), 3.02(4H,m), 3.31(4H,s), 3.98(3H,s), 5.07(lH,q), 7.03(lH,brs), 7.09(4H,s), 7.91(lH,s) Example 144 1H NMR(CDCb) : δ 218(3H,s), 2.27(6H,s), 2.41(3H,s), lδ 319(4H,brs), 3.22(4H,brs), 4.00(3H,s), 6.δδ(2H,s), 6.δ6(lH,s), 7.δO(lH,s) Example 145 1H NMR(CDCb) : δ 218(3H,s), 2.41 (3H,s), 316(4H,brs), 3.25(4H,s), 3.76(6H,s), 4.00(3H,s), 6.0δ(lH,s), 6.03(2H,s), 7.49(lH,s) Example 146 1H NMR(CDCb) : δ 218(3H,s), 2.40(3H,s), 318(4H,brs), 3.27(4H,brs), 4.00(3H,s), 6.27(3H,m), 7.δO(lH,s) 20 Example 147 1H NMR(CDCb) : δ 218(3H,s), 2.39(3H,s), 2.40(3H,s), 3.04(4H,s), 3.33(4H,s), 4.01(3H,s), 7.02(lH,d), 710(3H,s), 7.δ0(4H,s) Example 148 1H NMR(CDCb) : δ 210(3H,s), 2.31 (3H,s), 3.20(4H,s), 3.37(4H,s), 3.95(3H,s), 7.42(lH,s), 7.96(2H,s), 8.40(lH,s) Example 149 1H NMR(CDCb) : δ 2.09(3H,s), 2.26(3H,s), 2.31(3H,s), 25 311(4H,brs), 3.25(4H,brs), 4.00(3H,s), 6.80(2H,d), 7.06(2H,d), 7.42(lH,s) Example lδO 1H NMR(CDCb) : δ 1.74(3H,d), 2.28(9H,s), 312(2H,brs), 3.27(4H,brs), 3.6δ(4H,brs), 4.02(3H,s), 41δ(lH,q), 6.δ4(3H,s), 8.37(lH,s) Example lδl 1H NMR(CDCb) : δ 1.74(3H,d), 2.28(3H,s), 3.0δ(2H,brs), 3.26(4H,m), 3.67(4H,m), 3.82(6H,s), 4.01 (3H,s), 41δ(lH,q), 6.06(lH,s), 30 6.09(2H,s), 8.37(lH,s) Example lδ2 1H NMR(CDCb) : δ 1.74(3H,d), 2.28(3H,s), 31δ(2H,brs), 3.22(4H,s), 3.29(4H,s), 4.00(3H,s), 41δ(lH,q), 6.30(3H,m), 8.37(lH,s) Example 153 1H NMR(CDCb) : δ 1.74(3H,d), 2.28(3H,s), 2.39(3H,s), 310(2H,brs), 3.04(4H,s), 3.34(4H,s), 4.07(3H,s), 415(lH,q), 7.02(lH,d), 710(3H,s), 8.37(lH,s) 5 Example lδ4 1H NMR(CDCb) : δ 1.74(3H,d), 2.28(3H,s), 3.07(2H,brs), 3.20(4H,s), 3.3δ(4H,s), 3.90(3H,s), 415(lH,q), 7.97(2H,s), 8.35(lH,s), 8.42(lH,s) Example lδδ 1H NMR(CDCb) : δ 1.74(3H,d), 2.28(3H,s), 311(2H,brs), 3.20(8H,s), 4.00(3H,s), 41δ(lH,q), 617(lH,s), 6.74(2H,m), 8.37(lH,s) 10 Example lδ6 1H NMR(CDCb) : δ 1.26(3H,t). 2.28(3H,s), 3.08(2H,q), 317(4H,s), 3.24(4H,s), 3.78(3H,s), 4.07(3H,s), 6.8δ(2H,d), 7.00(lH,brs), 7.07(2H,d), 8.0δ(lH,s) Example 157 1H NMR(CDCb) : δ 1.25(6H,m), 2.70(2H,q), 2.95(4HJ), 3.08(2H,q), 3.26(4H,brs), 3.90(3H,s), 4.07(3H,s), 7.08(2H,m), 718(lH,t), lδ 7.24(lH,d), 8.40(lH,s) Example lδ8 1H NMR(CDCb) : δ 1.26(3H,t), 2.27(6H,s), 3.08(2H,q), 3.20(8H,s), 3.79(3H,s), 4.07(3H,s), 4.22(3H,s), 6.δ6(lH,s), 6.δ7(2H,s), 6.94(lH,s), 8.38(lH,s) Example 159 1H NMR(CDCb) : δ 1.26(3H,t), 3.07(2H,q), 3.21(8H,s), 20 3.77(6H,s), 3.79(3H,s), 4.07(3H,s), 6.05(lH,s), 6.09(2H,s), 6.95(lH,s), 8.37(lH,s) Example 160 1H NMR(CDCb) : δ 1.27(3HJ), 3.07(2H,q), 3.24(8H,s), 3.81(3H,s), 4.08(3H,s), 6.7δ(2H,s), 6.83(lH,s), 7.05(lH,brs), 8.29(lH,s) Example 161 1H NMR(CDCb) : δ 1.27(3H,t), 2.40(3H,s), 3.07(6H,m), 2δ 3.28(4H,brs), 3.88(3H,s), 4.07(3H,s), 7.0δ(2H,m), 712(3H,m), 8.38(lH,s) Example 162 1H NMR(CDCb) : δ 1.27(3H,t), 1.40(6H,t), 3.07(2H,q), 3.26(4H,s), 3.34(4H,s), 3.77(3H,s), 4.08(3H,s), 4.39(4H,q), 7.00(lH,brs), 7.70(2H,s), 817(lH,s), 8.3δ(lH,s) Example 163 1H NMR(CDCb) : δ 1.27(3H,t), 3.07(2H,q), 3.22(8H,d), 30 3.80(3H,s), 4.08(3H,s), 6.29(lH,t), 6.36(2H,d), 6.99(lH,brs), 8.32(lH,s) Example 164 1H NMR(CDCb) : δ 1.25(3H,t), 2.27(3H,s), 2.69(2H,q), 314(4H,d), 3.22(4H,d), 4.01(3H,s), 4.60(2H,s), 6.82(2H,d), 6.96(lH,brs), 7.06(2H,d), 7.78(lH,s) Example 16δ 1H NMR(CDCb) : δ 1.21 (3H,t), 1.26(3H,t), 2.67(4H,m), 2.91(4H,t), 3.27(4H,s), 4.01(3H,s), 4.66(2H,s), 7.06(2H,m), 716(1HJ), δ 7.21(lH,d), 7.82(lH,s) Example 166 1H NMR(CDCb) : δ 1.26(3H,t), 2.27(6H,s), 2.69(2H,q), 319(8H,d), 4.02(3H,s), 4.60(2H,s), 6.55(3H,s), 6.90(lH,s), 7.80(lH,s) Example 167 1H NMR(CDCb) : δ 1.26(3H,t), 2.69(2H,q), 319(8H,s), 3.76(6H,s), 4.02(3H,s), 4.60(2H,s), 6.03(lH,s), 6.08(2H,d), 6.88(lH,s), 10 7.79(lH,s) Example 168 1H NMR(CDCb) : δ 1.26(3H,t), 2.69(2H,q), 3.20(8H,s), 4.01(3H,s), 4.62(2H,s), 6.73(2H,s), 6.84(lH,s), 6.9δ(lH,brs), 7.77(lH,s) Example 169 1H NMR(CDCb) : δ 1.26(3H,t), 2.39(3H,s), 2.70(2H,q), 3.03(4H,d), 3.28(4H,s), 4.01(3H,s), 4.6δ(2H,s), 7.03(2H,m), 710(3H,m), lδ 7.80(lH,s) Example 170 1H NMR(CDCb) : δ 1.20(3H,t), 2.61(2H,q), 3.09(4H,s), 3.23(4H,s), 3.97(3H,s), 4.4δ(4H,s), 4.46(2H,s), 6.77(lH,s), 6.81 (2H,s), 6.99(lH,brs), 7.90(lH,s) Example 171 1H NMR(CDCb) : δ 1.2δ(3H,t), 2.68(2H,q), 3.21(4H,s), 20 3.22(4H,s), 4.01(3H,s), 4.62(2H,s), 6.27(lH,t), 6.33(2H,d), 7.05(lH,brs), 7.76(lH,s) Example 172 1H NMR(CDCb) : δ 3.24(8H,s), 3.76(6H,s), 41δ(3H,s), 6.00(lH,s), 6.08(2H,d), 7.31(lH,t), 7.3δ(lH,s), 7.43(lH,t), 7.δ7(lH,d), 7.71(lH,d), 8.06(lH,s) 2δ Example 173 1H NMR(CDCb) : δ 2.28(6H,s), 3.2δ(4H,s), 3.26(4H,s), 418(3H,s), 6.33(lH,brs), 6.56(lH,s), 6.58(2H,d), 7.33(lH,t), 7.47(lH,t), 7.δ7(lH,d), 7.78(lH,d), 8.0δ(lH,s) Example 174 1H NMR(CDCb) : δ 3.26(8H,s), 418(3H,s), 6.29(lH,t), 6.36(2H,d), 7.2δ(lH,brs), 7.34(1HJ), 7.49(lH,t), 7.δO(lH,d), 7.79(lH,d), 30 8.02(lH,s) Example 17δ 1H NMR(CDCb) : δ 316(4H,s), 3.36(4H,s), 3.84(3H,s), 418(3H,s), 6.86(lH,d), 6.9δ(2H,m), 7.02dH,m), 7.34(lH,t), 7.48(lH,t), 7.60(lH,d), 7.78(lH,d), 8.04(lH,s) Example 176 1H NMR(CDCb) : δ 3.2δ(4H,d), 3.32(4H,s), 418(3H,s), 6.77(lH,d), 6.85(2H,m), 717(lH,t), 7.3δ(lH,t), 7.50(lH,t), 7.59(lH,d), δ 7.79(lH,d), 7.99(lH,s) Example 177 1H NMR(CDCb) : δ 214(3H,s), 2.20(3H,s), 318(4H,d), 3.23(4H,d), 3.84(3H,s), 6.65(lH,s), 6.87(lH,t), 6.91(2H,d), 6.93(lH,brs), 7.25(2H,m), 7.36(lH,s) Example 178 1H NMR(CDCb) : δ 214(3H,s), 2.20(3H,s), 2.27(3H,s), 10 312(4H,d), 3.22(4H,d), 3.84(3H,s), 6.64(lH,s), 6.83(2H,d), 6.96(lH,brs), 7.07(2H,d), 7.3δ(lH,s) Example 179 1H NMR(CDCb) : δ 1.21 (3H,t), 2.20(3H,s), 2.21 (3H,s), 2.67(2H,q), 2.90(4H,t), 3.26(4H,s), 3.8δ(3H,s), 6.6δ(lH,s), 7.07(3H,m), 717(lH,t), 7.21(lH,d), 7.36(lH,s) lδ Example 180 1H NMR(CDCb) : δ 214(3H,s), 2.20(3H,s), 2.27(6H,s), 316(4H,d), 3.20(4H,d), 3.8δ(3H,s), 6.δ4(lH,s), 6.δ6(2H,s), 6.64(lH,s), 6.89(lH,brs), 7.37(lH,s) Example 181 1H NMR(CDCb) : δ 214(3H,s), 2.20(3H,s), 317(4H,s), 319(4H,s), 3.77(6H,s), 3.8δ(3H,s), 6.03(lH,s), 6.08(2H,d), 6.64(lH,s), 20 6.90(lH,brs), 7.36(lH,s) Example 182 1H NMR(CDCb) : δ 214(3H,s), 2.20(3H,s), 3.22(8H,s), 3.8δ(3H,s), 6.28(lH,t), 6.36(2H,d), 6.64(lH,s), 6.89(lH,brs), 7.36(lH,s) Example 183 1H NMR(CDCb) : δ 21δ(3H,s), 2.20(3H,s), 317(4H,d), 3.21(4H,d), 3.85(3H,s), 6.6δ(lH,s), 6.78(lH,d), 6.81(lH,d), 6.86(lH,s), 2δ 6.94(lH,brs), 716(lH,t), 7.33(lH,s) Example 184 1H NMR(CDCb) : δ 21δ(3H,s), 2.20(3H,s), 317(4H,d), 3.21(4H,d), 3.85(3H,s), 6.6δ(lH,s), 6.81(lH,d), 6.96(2H,brd), 7.02(lH,s), 710(1HJ), 7.33(lH,s) Example 185 1H NMR(CDCb) : δ 219(3H,s), 2.21(3H,s), 2.39(3H,s), 30 3.00(4H,d), 3.28(4H,s), 3.85(3H,s), 6.64(lH,s), 6.99(lH,brs), 7.03(lH,d), 710(3H,m), 7.36(lH,s) Example 186 1H NMR(CDCb) : δ 214(3H,s), 2.33(3H,s), 319(4H,s), 3.20(4H,s), 3.78(3H,s), 3.98(3H,s), 6.84(lH,s), 6.87(lH,t), 6.93(2H,m), 7.24(lH,d), 7.δ6(lH,s) Example 187 1H NMR(CDCb) : δ 213(3H,s), 2.27(3H,s), 2.32(3H,s), 313(4H,d), 319(4H,d), 3.77(3H,s), 3.98(3H,s), 6.81 (lH,s), 6.83(2H,d), 7.07(2H,d), 7.54(lH,s) Example 188 1H NMR(CDCb) : δ 213(3H,s), 2.28(9H,s), 317(4H,brs), 3.78(3H,s), 3.98(3H,s), 6.56(3H,s), 6.70(lH,s), 7.δ3(lH,s) Example 189 1H NMR(CDCb) : δ 214(3H,s), 2.32(3H,s), 317(8H,s), 0 3.77(9H,s), 3.98(3H,s), 6.04(lH,s), 6.08(2H,s), 6.81(lH,s), 7.δ3(lH,s) Example 190 1H NMR(CDCb) : δ 21δ(3H,s), 2.33(3H,s), 317(8H,s), 3.78(3H,s), 3.98(3H,s), 6.28(1HJ), 6.35(2H,d), 6.78(lH,s), 7.δO(lH,s) Example 191 1H NMR(CDCb) : δ 21δ(3H,s), 2.34(3H,s), 2.38(3H,s), 3.00(4H,s), 3.28(4H,s), 3.78(3H,s), 3.90(3H,s), 7.01(lH,s), 710(3H,s), 5 7.55(lH,s) Example 192 1H NMR(CDCb) : δ 216(3H,s), 2.34(3H,s), 3.20(4H,s), 3.37(4H,s), 3.78(3H,s), 3.90(3H,s), 6.78(lH,s), 7.47(lH,s), 7.97(2H,s), 8.42(lH,s) Example 193 1H NMR(CDCb) : δ 115(3H,t), 2.37(3H,s), 2.50(2H,q), 0 318(4H,brs), 3.23(4H,brs), 3.82(3H,s), 3.97(3H,s), 6.72(2H,s), 6.88(lH,s), 7.4δ(lH,s) Example 194 1H NMR(CDCb) : δ 1.26(3H,t), 3.07(2H,q), 3.22(8H,s), 3.79(3H,s), 3.86(3H,s), 4.07(3H,s), 6.29(lH,t), 6.36(2H,d), 8.29(lH,s) Example 19δ 1H NMR(CDCb) : δ 1.26(3H,t), 1.40(6H,t), 3.06(2H,q), δ 3.27(4H,brs), 3.38(4H,brs), 3.77(3H,s), 3.81(3H,s), 4.07(3H,s), 4.38(4H,q), 7.76(2H,s), 817(lH,s), 8.30(lH,s) Example 196 1H NMR(CDCb) : δ 1.24(3H,t), 2.67(2H,q), 3.21 (8H,s), 3.78(3H,s), 4.01 (3H,s), 4.δ9(2H,s), 4.63(4H,s), 6.84(2H,m), 6.88(2H,s), 7.78(lH,s) 0 Example 197 1H NMR(CDCb) : δ 214(3H,s), 2.20(3H,s), 2.27(3H,s), 313(4H,brs), 3.24(4H,brs), 3.78(3H,s), 3.84(3H,s), 6.64(lH,s), 6.84(2H,brs), 7.07(2H,d), 7.27(lH,brs) Example 198 1H NMR(CDCb) : δ 214(3H,s), 2.20(3H,s), 2.2δ(6H,s), 316(4H,brs), 3.22(4H,brs), 3.79(3H,s), 3.83(3H,s), 6.54(2H,s), 6.64(lH,s), 6.81(lH,brs), 7.27(lH,brs) δ Example 199 1H NMR(CDCb) : δ 211(3H,brs), 216(3H,s), 2.36(3H,s), 3.24(4H,t), 3.80(4H,s), 3.92(3H,s), 6.8δ(lH,brs), 6.89(lH,t), 6.9δ(2H,d), 7.28(2H,t) Example 200 1H NMR(CDCb) : δ 211(3H,brs), 216(3H,s), 2.28(3H,s), 2.36(3H,s), 319(4H,t), 3.80(4H,brs), 3.92(3H,s), 6.86(3H,brd), 7.08(2H,d) 10 Example 201 1H NMR(CDCb) : δ 0.92(3H,t), 1.3δ(2H,m), 1.5δ(2H,m), 210(3H,brs), 216(3H,s), 2.36(3H,s), 2.54(2H,t), 3.20(4H,t), 3.80(4H,brs), 3.92(3H,s), 6.87(3H,brd), 7.09(2H,d) Example 202 1H NMR(CDCb) : δ 210(3H,brs), 216(3H,s), 2.89(6H,s), 2.36(3H,s), 3.21(4H,t), 3.78(4H,brs), 3.92(3H,s), 6.δ6(lH,s), 6.δ9(2H,s), lδ 6.84(3H,brs) Example 203 1H NMR(CDCb) : δ 210(3H,brs), 216(3H,s), 2.36(3H,s), 3.22(4H,t), 3.79(7H,brs), 3.92(3H,s), 6.84(lH,brs), 6.9δ(4H,s) Example 204 1H NMR(CDCb) : δ 210(3H,brs), 216(3H,s), 2.36(3H,s), 3.24(4H,brs), 3.78(10H,s), 3.92(3H,s), 6.0δ(lH,s), 611(2H,s), 6.84(3H,brs) 20 Example 20δ 1H NMR(CDCb) : δ 210(3H,brs), 216(3H,s), 2.36(3H,s), 3.24(4H,t), 3.78(4H,t), 6.28(lH,t), 6.39(2H,d), 6.84(lH,s) Example 206 1H NMR(CDCb) : δ 210(3H,s), 216(3H,s), 2.36(3H,s), 3.2δ(4H,t), 3.78(4H,t), 3.92(3H,s), 6.77(2H,s), 6.84(2H,s) Example 207 1H NMR(CDCb) : δ 210(3H,brs), 217(3H,s), 2.36(3H,s), 2δ 3.2δ(4H,brs), 3.79(4H,brs), 3.92(3H,s), 6.84(2H,m), 7.00(lH,d), 7.06dH,brs), 713(1HJ) Example 208 1H NMR(CDCb) : δ 212(3H,s), 217(3H,s), 2.37(3H,s), 3.δO(4H,t), 3.88(4H,brs), 3.93(3H,s), 6.87dH,brs), 8.00(2H,d), 8.43(lH,s) Example 209 1H NMR(CDCb) : δ 1.41(6H,t), 211(3H,brs), 21δ(3H,s), 30 2.37(3H,s), 3.36(4H,brs), 3.83(4H,brs), 3.92(3H,s), 4.40(4H,q), 6.85(lH,brs), 7.78(2H,s), 818(lH,s) Example 210 1H NMR(CDCb) : δ 1.67(3H,t), 210(3H,s), 2.39(3H,s), 2.δl(2H,q), 3.2δ(4H,t), 3.80(4H,t), 3.92(3H,s), 6.90(2H,t), 6.9δ(2H,d), 7.29(2HJ) Example 211 1H NMR(CDCb) : δ 117(3H,t), 210(3H,brs), 2.39(3H,s), δ 2.52(2H,q), 313(4H,brs), 3.84(4H,brs), 3.88(3H,s), 3.93(3H,s), 6.89(2H,brd), 6.93(2H,m), 7.04(lH,m) Example 212 1H NMR(CDCb) : δ 116(3H,t), 2.09(3H,s), 2.39(3H,s), 2.51(2H,q), 3.23(4H,t), 3.79(10H,s), 3.92(3H,s), 6.0δ(lH,s), 611(2H,d), 6.87(lH,s) 10 Example 213 1H NMR(CDCb) : δ 118(3H,t), 1.2δ(3HJ), 211(3H,brs), 2.40(3H,s), 2.52(2H,q), 2.72(2H,q), 2.96(4H,brs), 3.79(4H,brs), 3.94(3H,s), 6.88(lH,brs), 7.09(2H,m), 718(lH,t), 7.24(lH,d) Example 214 1H NMR(CDCb) : δ 116(3H,t), 2.09(3H,s), 2.29(6H,s), 2.39(3H,s), 2.δl(2H,q), 3.22(4HJ), 3.78(4HJ), 3.92(3H,s), 6.δ6(lH,s), lδ 6.δ9(2H,s), 6.87(lH,s) Example 21δ 1H NMR(CDCb) : δ 116(3H,t), 211(3H,brs), 2.40(3H,s), 2.δl(2H,q), 3.27(4H,s), 3.80(4H,s), 3.92(3H,s), 6.28dH,t), 6.39(2H,d), 6.84(lH,s) Example 216 1H NMR(CDCb) : δ 117(3H,t), 212(3H,brs), 2.40(3H,s), 20 2.δ2(2H,q), 3.27(4H,s), 3.80(4H,s), 3.92(3H,s), 6.77(2H,d), 6.84(lH,s), 6.90(lH,brs) Example 217 1H NMR(CDCb) : δ llδ(3H,t), 2.03(3H,brs), 2.38(3H,s), 2.50(2H,q), 2.90(4H,brs), 3.51(4H,brs), 3.90(3H,s), 6.82(lH,d), 7.03(lH,d), 710(lH,t), 7.27(3H,m), 7.39(2H,t), 7.61(2H,d) 2δ Example 218 1H NMR(CDCb) : δ llδ(3H,t), 213(3H,brs), 2.41 (3H,s), 2.52(2H,q), 3.52(4H,brs), 3.93(7H,s), 6.87(lH,brs), 7.99(2H,d), 8.44(lH,s) Example 219 1H NMR(CDCb) : δ 117(3H,t), 210(3H,brs), 2.39(3H,s), 2.42(3H,s), 2.52(2H,q), 3.06(4H,s), 3.83(4H,s), 3.93(3H,s), 6.88(lH,brs), 7.0δ(lH,m), 712(3H,s) 30 Example 220 1H NMR(CDCb) : δ 210(3H,brs), 2.73(3H,s), 3.23(4H,brs), 3.86(10H,s), 3.89(3H,s), 6.05(lH,s), 611(2H,s), 7.62(lH,brs) Example 221 1H NMR(CDCb) : δ 210(3H,brs), 2.29(6H,s), 2.73(3H,s), 3.23(4H,brs), 3.82(4H,brs), 3.86(3H,s), 3.99(3H,s), 6.57(3H,m), 7.62(lH,brs) Example 222 1H NMR(CDCb) : δ 210(3H,s), 2.73(3H,s), 3.27(4H,t), 3.83(4H,s), 3.86(3H,s), 4.00(3H,s), 6.30(lH,t), 6.40(2H,d), 7.64(lH,brs) 5 Example 223 1H NMR(CDCb) : δ 210(3H,brs), 2.73(3H,s), 314(4H,brs), 3.86(7H,s), 3.89(3H,s), 4.00(3H,s), 6.89(lH,d), 6.9δ(2H,m), 7.04(lH,brm), 7.62(lH,brs) Example 224 1H NMR(CDCb) : δ 211(3H,brs), 2.73(3H,s), 3.26(4H,t), 3.8δ(7H,s), 4.00(3H,s), 6.91(lH,t), 6.95(2H,d), 7.30(2H,t), 7.63(lH,brs) 10 Example 225 1H NMR(CDCb) : δ 210(3H,s), 2.27(3H,s), 2.72(3H,s), 3.20(4H,t), 3.83(4H,s), 3.85(3H,s), 4.00(3H,s), 6.87(2H,d), 7.09(3H,d), 7.63(lH,brs) Example 226 1H NMR(CDCb) : δ 211(3H,brs), 2.73(3H,s), 3.27(4H,brs), 3.86(7H,s), 4.00(3H,s), 6.81(lH,d), 6.8δ(lH,d), 6.90(lH,s), 719(lH,t), lδ 7.63(lH,brs) Example 227 1H NMR(CDCb) : δ 212(3H,brs), 2.29(6H,s), 2.δ3(3H,s), 2.67(3H,s), 3.24(4H,brs), 3.83(4H,brs), 4.00(3H,s), 6.δ8(lH,s), 6.60(2H,s), 7.47(lH,brs) Example 228 1H NMR(CDCb) : δ 212(3H,brs), 2.δ3(3H,s), 2.68(3H,s), 20 3.25(4H,t), 3.79(6H,s), 3.82(4H,brs), 4.00(3H,s), 6.06(lH,s), 612(2H,d), 7.46(lH,brs) Example 229 1H NMR(CDCb) : δ 212(3H,s), 2.δ3(3H,s), 2.68(3H,s), 3.26(4H,t), 3.77(4H,t), 4.00(3H,s), 6.89(3H,d), 719(2H,d), 7.46(lH,s) Example 230 1H NMR(CDCb) : δ 212(3H,brs), 212(3H,s), 2.53(3H,s), 2δ 2.68(3H,s), 3.22(4H,s), 3.8δ(3H,brs), 4.00(3H,s), 6.87(2H,d), 710(2H,d), 7.4δ(lH,s) Example 231 1H NMR(CDCb) : δ 212(3H,s), 2.δδ(3H,s), 2.68(3H,s), 3.32(4H,brs), 3.86(4H,brs), 4.01(3H,s), 6.38(3H,m), 7.47(lH,brs) Example 232 1H NMR(CDCb) : δ 212(3H,s), 2.43(3H,s), 2.54(3H,s), 30 2.68(3H,s), 3.07(4H,brs), 3.86(4H,brs), 4.00(3H,s), 7.06(lH,m), 713(3H,m), 7.46(lH,brs) Example 233 1H NMR(CDCb) : δ 1.28(3H,t), 213(3H,brs), 2.29(3H,s), 311(2H,q), 3.21(4H,brs), 3.8δ(7H,brs), 4.00(3H,s), 6.89(2H,brs), 7.08(2H,d), 7.62(lH,brs) Example 234 1H NMR(CDCb) : δ 1.24(3H,t), 1.28(3H,t), 212(3H,brs), δ 2.72(2H,q), 2.96(4H,brs), 310(2H,q), 3.81(4H,brs), 3.86(3H,s), 4.00(3H,s), 7.09(2H,m), 719(lH,t), 7.24(lH,d), 7.60(lH,brs) Example 235 1H NMR(CDCb) : δ 1.28(3H,t), 210(3H,brs), 2.29(6H,s), 311(2H,q), 3.23(4H,brs), 3.82(4H,brs), 3.85(3H,s), 4.00(3H,s), 6.δ7(lH,s), 6.δ9(2H,s), 7.δ9(lH,brs) 0 Example 236 1H NMR(CDCb) : δ 1.28(3H,t), 210(3H,brs), 310(2H,q), 3.24(4H,brs), 3.79(6H,s), 3.81(4H,brs), 3.8δ(3H,s), 4.00(3H,s), 6.06(lH,s), 611(2H,s), 7.59(lH,brs) Example 237 1H NMR(CDCb) : δ 1.28(3HJ), 210(3H,brs), 311(2H,q), 3.28(4H,brs), 3.82(4H,brs), 3.85(3H,s), 4.00(3H,s), 6.77(2H,d), 6.85(lH,s), 5 7.60(lH,brs) Example 238 1H NMR(CDCb) : δ 1.28(3H,t), 210(3H,brs), 2.43(3H,s), 3.06(6H,m), 3.86(7H,brs), 4.01(3H,s), 7.06(lH,s), 712(3H,s), 7.60(lH,brs) Example 239 1H NMR(CDCb) : δ 1.28(3H,t), 1.43(6H,t), 211(3H,brs), 312(2H,q), 3.37(4H,brs), 3.86(7H,s), 4.01(3H,s), 4.41(4H,q), 7.60(lH,brs), 0 7.79(2H,s), 818(lH,s) Example 240 1H NMR(CDCb) : δ 1.28(3H,t), 210(3H,brs), 310(2H,q), 3.28(4H,brs), 3.82(4H,brs), 3.86(3H,s), 4.00(3H,s), 6.30(lH,t), 6.39(2H,d), 7.60(lH,brs) Example 241 1H NMR(CDCb) : δ 2.07(3H,s), 3.27(4H,t), 3.79(6H,s), δ 3.86(4HJ), 410(3H,s), 6.06(lH,m), 612(2H,d), 7.32(1HJ), 7.36(lH,s), 7.48(lH,t), 7.61(lH,d), 7.80(lH,d) Example 242 1H NMR(CDCb) : δ 2.07(3H,s), 2.30(6H,s), 3.2δ(4H,s), 3.86(4H,s), 410(3H,s), 6.58(lH,s), 6.60(2H,s), 7.32(lH,t), 7.36(lH,s), 7.49(lH,d), 7.80(lH,d) 0 Example 243 1H NMR(CDCb) : δ 2.09(3H,brs), 3.27(4H,s), 3.87(4H,s), 410(3H,s), 6.29(lH,t), 6.39(2H,d), 7.32(lH,t), 7.37(lH,s), 7.49(1HJ), 7.80(lH,d) Example 244 1H NMR(CDCb) : δ 2.09(3H,brs), 31δ(4HJ), 3.89(4H,s), 411(3H,s), 6.89(lH,d), 6.96(2H,m), 7.04(lH,m), 7.32(lH,t), 7.38(lH,brs), 7.48(1HJ), 7.62(lH,d), 7.80(lH,d) δ Example 24δ 1H NMR(CDCb) : δ 210(3H,brs), 3.29(4H,t), 3.88(4H,brs), 410(3H,s), 6.82(lH,dd), 6.88(lH,d), 6.92(lH,s), 7.20(lH,t), 7.33(lH,t), 7.40(lH,brs), 7.49(lH,t), 7.62(lH,d), 7.80(lH,d) Example 246 1H NMR(CDCb) : δ 214(3H,brs), 217(3H,s), 2.22(3H,s), 3.2δ(4H,t), 3.78(7H,s), 6.60(lH,brs), 6.66(lH,s), 6.89(lH,t), 6.9δ(2HJ), 10 7.29(2H,t) Example 247 1H NMR(CDCb) : δ 214(3H,brs), 217(3H,s), 2.22(3H,s), 2.28(3H,s), 319(4HJ), 3.77(7H,s), 6.60(lH,brs), 6.66(lH,s), 6.86(2H,d), 7.08(2H,d) Example 248 1H NMR(CDCb) : δ 1.2δ(3H,t), 214(3H,brs), 218(3H,s), lδ 2.23(3H,s), 2.72(2H,q), 2.96(4H,brs), 3.7δ(4H,brs), 3.79(3H,s), 6.60(lH,brs), 6.67(lH,s), 7.08(2H,t), 718(lH,t), 7.24(lH,m) Example 249 1H NMR(CDCb) : δ 212(3H,s), 216(3H,s), 2.22(3H,s), 2.29(6H,s), 3.21(4H,t), 3.74(4HJ), 3.77(3H,s), 6.δ5(lH,s), 6.59(3H,s), 6.6δ(lH,s) 20 Example 2δ0 1H NMR(CDCb) : δ 212(3H,s), 216(3H,s), 2.22(3H,s), 3.23(4H,t), 3.74(4H,t), 3.77(3H,s), 3.78(6H,s), 6.04(lH,s), 612(2H,d), 6.δ9(lH,s), 6.6δ(lH,s) Example 2δl 1H NMR(CDCb) : δ 211(3H,s), 216(3H,s), 2.22(3H,s), 3.2δ(4H,t), 3.74(4H,t), 3.77(3H,s), 6.28(1HJ), 6.39(2H,d), 6.δ9(lH,s), 25 6.66(lH,s) Example 252 1H NMR(CDCb) : δ 214(3H,brs), 217(3H,s), 2.22(3H,s), 3.2δ(4H,t), 3.76(4H,brs), 3.78(3H,s), 6.61(lH,brs), 6.66(lH,s), 6.83(2H,m), 6.90(lH,s), 718(lH,t) Example 2δ3 1H NMR(CDCb) : δ 214(3H,brs), 217(3H,s), 2.23(3H,s), 30 3.2δ(4H,t), 3.78(7H,s), 6.61(lH,brs), 6.66(lH,s), 6.8δ(lH,d), 6.98(lH,d), 7.06(lH,s), 712(1HJ) Example 2δ4 1H NMR(CDCb) : δ 214(3H,brs), 217(3H,s), 2.22(3H,s), 2.42(3H,s), 3.06(4H,t), 3.78(7H,s), 6.60(lH,brs), 6.66(lH,s), 7.06(lH,m), 712(3H,s) δ Antitumor activities of the compounds of the present invention were tested in vitro against δ kinds of human tumor cell lines and a leukemia tumor cell line. The method and result of the in vitro tests is as follows. 10 Experimental 1 : In vitro antitumor effect against human tumor cell lines. A. Tumor cell line : Aδ49 (human non- small lung cell) SKOV-3 (human ovarian) lδ HCT-lδ (human colon) XF 498 (human CNS) SKMEL-2 (human melanoma) B. SRB Assay Method. 20 a. Human solid tumor cell lines, Aδ49(non-small lung cell), SKMEL-2(melanoma), HCT-lδ(colon), SKON-3(ovarian), XF-498(CΝS) were cultured at 37 °C in δ% C0 2 incubators using RPMI 1640 media containing 10% FBS, while they were transfer-cultured successively once or twice per week. Cell cultures were dissolved in a solution of 2δ 0.2δ% trypsin and 3 mM CDTA PBS(-) and then cells were separated from media which the cells were sticked on. b. δ iO 3 — 2 X 10 4 cells were added into each well of 96- well plate and cultured in δ% CO2 incubator, at 37 °C, for 24 hours. c. Each sample drug was dissolved in a little DMSO and diluted with 30 the used medium to a prescribed concentration for experiments, wherein the final concentration of DMSO was controlled below 0.δ%. d. Medium of each well cultured for 24 hours as above b. was removed by aspiration. Each 200 l of drug samples prepared in c. was added into each well and the wells were cultured for 48 hours. Tz(time zero) plates were collected at the point of time drugs were added. δ e. According to the SRB assay method, cell fixing with TCA, staining with 0.4% SRB solution, washing with 1% acetic acid and elution of dye with lOmM Tris solution were carried out on Tz plates and culture-ended plates, whereby OD values were measured at 520 nm. 0 C. Calculation of result a. Time zero(Tz) value was determined with measuring the SRB protein amounts of the Tz plates collected at the point of time drugs were added. b. Control value(C) was determined with the OD values of wells 5 untreated with a drug. c. Drug-treated test value(T) was determined with the OD values of drug-treated wells. d. Effects of drugs were estimated with growth stimulation, net growth inhibition, net killing etc., being calculated from Tz, C and T. 0 e. If T ≥ Tz, cellular response function was calculated by lOOx(T-Tz)ΛC-Tz), and if T < Tz, by 100 x (T-Tz)/Tz. The results are shown in the next table 1. * REFERENCE 5 D P. Skehan, R. Strong, D Scudiero, A. Monks, J. B. Mcmahan, D. T. Vistica, J. Warren, H. Bokesh, S. Kenny and M. R. Boyd : Proc. Am. Assoc. Cancer Res., 30, 612(1989) 2) L. V. Rubinstein, R. H. Shoemaker, K. D. Paull, R. M. simon, S. Tosini, P. Skehan, D. Scudiero, A. Monks and M. R. boyd. ; J. Natl. 0 Cancer ist, 82, 1113(1990) 3) P. Skehan, R. Strong, D. Scudiero, A. monks, J. B. Mcmahan, D. T. - Ill - Nistica, J. Warren, H. Bokesh, S. Kenny and M. R. Boyd.J, Νatl. Cancer Ins., 82, 1107(1990) D. Results. 5 It was found that all the tested compounds of the present invention have superior antitumor activities to the control, cisplatin. Table 1. 10 lδ 20 2δ 30 10 Experimental 2. In vitro antitumor effects against animal leukemia cells. lδ A. Material : Tumor cell line '• P388 (mouse lymphoid neoplasma cell) B. Method : Dye Exclusion Assay. 1) Concentrations of P388 cells being cultured in RPMI 1640 media 20 containing 10% FBS were regulated to 1 10 6 cells/ml. 2) Sample drugs of respective concentrations diluted in the ratio of log doses were added into each cell culture and cultured at 37 °C, for 48 hours, in δ0% CO2 incubator, and then viable cell numbers were measured by dye exclusion test using trypan blue. 2δ 3) Concentrations of sample compounds showing δO % cell growth inhibition compared with the control(ICso) were determined and listed in the table 2 below. * REFERENCE 30 1) P. Skehan, R. Strong, D. Scudiero, A. Monks, J. B. Mcmahan, D. T. Nistica, J. Warren, H. Bokesh, S. Kenney and M. R. Boyd. ' • Proc. Am. Assoc. Cancer Res., 30, 612(1989). 2) L. V. Rubinstein, R. H. Shoemaker, K. D. Paull, R. M. Simon, S. Tosini, P. Skehan, D. Scudiero, A. Monks, J. Natl. Cancer Inst., 82, 1113(1990) δ 3) P. Skehan, R. Strong, D. Scudiero, J. B. Mcmahan, D. T. Nistica, J. Warren, H. Bokesch, S. Kenney and M. R. Boyd. : J. Νatl. Cancer Inst., 82, 1107(1990) C. Results 10 As the results of measurement of antitumor activities of compounds of the present invention against P388 mouse leukemia cells, it was found that all the compounds tested have equal to or higher antitumor activities than those of the control drug, mitomycin C. lδ 20 2δ 30 Experimental 3. Acute toxicity test (LD50) A. Method : Litchfield-Wilcoxon method. 6 weeks old ICR mice(male 30±2.0g) were fed freely with solid feed and water at room temperature, 23± 1 ° C at humidity 60 ±5%. Sample drugs were injected into abdominal cavities of mice, while each group comprises 6 mice. Observed during 14 days, external appearances and life or death were recorded, and then, visible pathogenies were observed from dead animals by dissection. LD50 value was calculated by Litchfiled-wilcoxon method. B. Result The results are shown at the next table 3. Table 3 10 lδ As described above, it was found that the compounds of the present invention are more safer than cisplatin, whereby the present compounds may solve problems of known drugs by the prior art such as restriction 20 of dosage, toxicity, etc. 2δ 30

Claims: What is claimed: 1. A compound of the general formula(I) (I) 10 wherein Ri and R2 are independently hydrogen, Cι ~ C 4 alkyl, Cι-C 4 alkylcarboxyl, C1-C4 alkylcarbonyl, C1-C4 alkoxy, Cι-C 4 hydroxyalkyl, C1-C4 aminoalkyl or Ci-C hydroxyiminoalkyl, or Ri and R2 are fused to form C3-C4 unsaturated ring! R3, R4, R5, Rβ and R7 are independently hydrogen, halogen, hydroxy, lδ nitro, amino, C1-C4 alkyl, C1-C4 alkylcarboxyl, C1-C4 alkylcarbonyl, C1-C4 alkoxy or C1-C4 thioalkoxy; Rs is C1-C4 alkyl; Y is oxygen, sulphur, amino, substituted amino or C1-C4 thioalkyl; Z is C1-C4 alkoxy, C1-C4 alkyl, C1-C4 alkylamino or C1-C4 thioalkoxy; 20 Xi and X2 are independently carbon or nitrogen; and —N-C— and — C-Y — may form a single bond or a double bond provided that if —N-C— forms a single bond, — C-Y — forms a bouble bond, and if —C-Y — forms a single bond, — N ~ c— forms a bouble bond and Rs is nonexistent; or pharmaceutically acceptable acid addition 2δ salts thereof. 2. A process for the preparation of compound of the general formula (la) or a pharmaceutically acceptable acid addition salt thereof comprising 30 reacting a compound of the general formula (2) with a -C(=Y)- group-providing agent in a conventional organic solvent to obtain a compound of the general formula (3) and successively reacting the compound of the general formula (3) with a compound of the general formula (4) to give the compound of the general formula (δ), and reacting the compound of the formula (δ) with an alkylating agent or arylating agent in the presence of a base to give the compound of the general formula (la). wherein Ri, R2, R3, R4, Rs, RΘ, R7, Rs, Xi, X2, Y and Z are as defined above, and Lie is a conventional leaving group. 25 3. A process for the preparation of compound of the general formual (lb) comprising reacting a compound of the general formula (II) with an alkylating agent in the presence of a base to give a compound of the general 30 formula (F) and reacting the compound of the formula (D with a substituted or unsubstitued amine in the presence of a base to give a compound of the general formula (lb). (II) (r) (lb) wherein Ri, R2, R3, R4, Rs, Re, R7, Xi, X2, Y and Z are as defined above, and R x is Cι-C 4 alkyl. 20 2δ 30

Inventors: CHO EUI-HWAN, CHUNG SUN-GAN, JOO JEONG-HO, KANG DONG-WOOK, KWON HO-SEOK, LEE SUN-HWAN, LEE YOUNG-HEE, CHO, EUI-HWAN, CHUNG, SUN-GAN, JOO, JEONG-HO, KANG, DONG-WOOK, KWON, HO-SEOK, LEE, SUN-HWAN, LEE, YOUNG-HEE
Applicants: CHO EUI HWAN, CHUNG SUN GAN, JOO JEONG HO, KANG DONG WOOK, KWON HO SEOK, LEE SUN HWAN, LEE YOUNG HEE, SAMJIN PHARM CO LTD, CHO, EUI-HWAN, CHUNG, SUN-GAN, JOO, JEONG-HO, KANG, DONG-WOOK, KWON, HO-SEOK, LEE, SUN-HWAN, LEE, YOUNG-HEE, SAMJIN PHARMACEUTICAL CO., LTD.
Application year: 2000
Main classification: C07D295
IPC codes: C07D213, C07D241, C07D295